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The Inflammatory Consequences of Stress and Adiposity 
Cathy A. Bykowski 
ABSTRACT 
The inflammatory process is important in protecting the body against the invasion of 
pathogens, but recent research has suggested that a long-term inflammatory response may 
lead to chronic diseases (e.g., Black, 2003; Wu, Dorn, Donahue, Sempos, & Trevisan, 
2002).  Two factors that have been implicated in the inflammatory and disease processes 
are stress and obesity (Black, 2003).  While their individual lines of research continue to 
grow, few researchers have attempted to integrate these factors into one model to explain 
their effects on inflammation.  This study aimed to replicate previous findings suggesting 
relationships between stress, obesity and inflammation and test an integrated model of 
stress and obesity by examining a possible interaction between the effects of stress and 
obesity on inflammation.  Socioeconomic Status (SES) and depression were employed to 
examine the association between stress and the inflammatory marker, c-reactive protein 
(CRP).  The study utilized the data resulting from the National Health and Nutrition 
Examination Survey (NHANES; National Center for Health Statistics, 2006).  Included 
in the dataset are 4998 adults (2416 males and 2582 females) ranging in age from 18 
years to over 85 years (M = 47.13, SD = 20.86).  A subsample (N = 589) completed the 
Major Depression module of the Composite International Diagnostic Interview (CDCI).  
The results indicate that BMI, WC, income, education, and depression symptoms 
vii 
significantly predict CRP.  The data also suggest an interaction between the adiposity 
variables and the SES variables.  This supports the hypothesis that the inflammatory 
effect of stress on an individual is moderated by adiposity. 
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The Inflammatory Consequences of Stress and Adiposity 
 The inflammatory process is important in protecting the body against the invasion 
of pathogens, but recent research has suggested that a long-term inflammatory response 
may lead to chronic diseases such as insulin resistance (Wu, Dorn, Donahue, Sempos, & 
Trevisan, 2002), atherosclerosis, type 2 diabetes, and metabolic syndrome (Black, 2003).  
The severity of these illnesses underscores the need to understand the mechanisms that 
lead to the prolonged inflammation with which they are associated.  Two factors that 
have been implicated in the inflammatory and disease processes are stress and obesity 
(Black, 2003).  Both factors have been associated with increased inflammatory markers 
(e.g. Brydon, Edwards, Mohamed-Ali, & Steptoe, 2004; Lemieux et al, 2001; McCarty, 
1999; Owen, Poulton, Hay, Mohamed-Ali, & Steptoe, 2003) as well as increased risk for 
these inflammatory diseases (e.g. Burton, Foster, Hirsch & van Itallie, 1985; Wellen & 
Hotamisligil, 2005).  While their individual lines of research continue to grow, few 
researchers have attempted to integrate stress and obesity into one model to explain their 
effects on inflammation.  This paper will discuss the previous research in the distinct 
areas of stress and obesity and will then examine a model to explain possible interactions 
of the two factors.   
The human body is equipped with a complex security system that is activated 
when faced with a threat due to injury or infection.  Granulocytes are the major group of 
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cells that respond to most threats by migrating to the site of infection or injury, destroying 
the threat by secreting toxic chemicals, and then consuming the left-over particles and 
injured tissue.  Some granulocytes also release cytokines which send out messages to the 
remainder of the body to prepare it for the impending attack (Segerstrom & Miller, 2004).    
The cytokines, particularly interluekin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α), 
initiate inflammation through the acute phase response (APR).  The result is fever, a 
sickness response, and the production of acute phase proteins (APPs), such as c-reactive 
protein (CRP), which enable the body to defend itself against the threat (Black, 2003).  
The inflammatory response is intended to protect and heal the body.  However, recent 
studies have begun to describe complications that can arise when this process occurs too 
frequently or persists for an extended period of time (Black, 2003; Wu et al., 2002).  A 
better understanding of the factors that cause inflammation may lead to more effective 
remedies and prevention programs to decrease the incidence of inflammatory diseases.  
Stress and the Inflammatory Response 
 The definition of stress is at the center of one of psychology’s oldest debates.  For 
many decades it has been unclear as to whether stress should be defined in terms of a 
stimulus or response.  Hans Selye may be one of the most influential early stress 
researchers and his work, which focused on physiological reactions to a stimulus, shaped 
the field for many decades.  He first used the term “stress” in 1946 to describe an outside 
influence that acts on an organism, a stimulus.  He continued to use that definition until 
1950, when he proposed that “stress” be defined in terms of an internal reaction to an 
outside influence, or “stressor” (Mason, 1975).  Perhaps this surprising change in 
definitions by one of the great leaders in the field was the beginning of the confusion over 
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how to define stress.  Today, researchers are forced to define stress for their own project, 
with some researchers studying the stimulus, some studying a response, and some 
studying an interaction of the two (Mason, 1975).  Because of the vague nature of the 
term “stress” it can sometimes be unclear as to whether a particular outcome of stress is 
due to the stimulus or the response to the stimulus.  For this reason, this paper examines 
both aspects of stress.  The effects of stress will be measured in terms of the stimuli, or 
stressor, and in terms of the mental state that is the psychological reaction to a stressor or 
stressors.   
From the early research of Selye and Cannon, scientists have acknowledged the 
physiological impact of stress (Mason, 1975).  As researchers learn more about the 
biology of the human body and its responses to stress, it is becoming clearer that stressors 
and injury or infection result in the activation of the same pathways and the release of the 
same biochemicals.  The body’s response to stress is characterized by the release of 
corticosteroids and catecholamines, such as epinephrine and norepinephrine.  These 
hormones, much like granulocytes, initiate the production of cytokines, commencing the 
APR.  The connection between the two systems may be an evolutionary adaptation 
mechanism.  When the body is faced with a threat the sympathetic nervous system is 
activated so that the person is ready to fight or flee the threat.  In addition, the 
inflammatory system is activated so that the body is ready to battle any infection or injury 
that results from the fighting or fleeing (Black, 2002).  This relationship between the two 
systems will be examined with a focus on the inflammatory results of stress (both as a 
stressor and a psychological reaction to a stressor).   
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Stress as a stressor.  As previously mentioned, the first scientific definition of 
stress was that of a stimulus.  This definition is still used in both science and everyday 
life.  The field of physics refers to stress when referring to the force that is being placed 
on a material (Mason, 1975).  In common language one talks about the stress of a 
deadline or the stress of school, with the focus on the stressor, not the reaction to the 
force or the deadline.  Stress researchers employ this definition when they expose 
someone to “stress” by requiring them to give a speech, perform mental arithmetic, or to 
complete a difficult task, such as tracing a star in a mirror.  Often it is understood that the 
force of the stimulus is the stress, and the focus is not on the individual’s psychological 
reaction to the stress.  It is assumed that a person has been exposed to stress when 
completing these tasks, although the individual is often not asked about his or her 
experience or reaction to the task.  These studies benefit from the concrete definition of 
stress, it is much easier to measure how long a speech is than to have a person quantify 
his or her psychological reaction to a speech.  Experimenters that employ the stressor 
definition of stress in laboratory experiments have more control over the stress than 
scientists that define stress in terms of an individual’s reaction (Steptoe & Vogele, 1991).    
Common laboratory stressors include mental arithmetic, giving a speech, and 
performing uncommon and difficult tasks (Steptoe & Vogele, 1991).  Researchers have 
also studied common real-world stressors, such as caring for a chronically ill family 
member, death of a loved one and socioeconomic status (SES).  It is important to point 
out that many researchers who study these concepts are looking for a specific reaction, 
such as increased heart rate or blood pressure.  However, what they define as “stress” is 
the stressor.  They may look for a reaction to stress but the reaction is not the stress.  The 
5 
definition of stress that is being employed is based on a force outside the body.  In order 
to distinguish between “stress” as a stimuli and “stress” as a reaction, the term “stressor” 
will be used to indicate a force outside the body, or a stimulus.   
The study of inflammatory responses to stressors, in both animals and humans, 
has been growing exponentially in recent years.  While the results are not always 
consistent (e.g., Goebel, Mills, Irwin, & Ziegler, 2000; Heinz et al., 2003; Lutgendorf, 
Logan, Costanzo, & Lubaroff, 2004; Owen & Steptoe, 2003), many experimenters have 
found a relationship between inflammatory markers, such as cytokines and APPs, and 
exposure to a stressor.  Some of the first subjects to be studied were rats who 
demonstrated a relationship between IL-6 and stress.  When rats were exposed to a 
physical stressor (e.g. electric foot-shock), a psychological stressor (e.g., a conditioned 
aversive stimulus) or a stressor that has both psychological and physical components 
(e.g., restraint), the rat’s plasma level of IL-6 increased (Zhou, Kusnecov, Shurin, and 
DePaoli, 1993).  This early animal research quickly led to the study of inflammation in 
response to stressors in humans.  Increases in concentrations of the cytokines, such as IL-
6 and TNF-α, have been observed following laboratory speech tasks (Ackerman, 
Martino, Heyman, Moyna, & Rabin, 1998), physical exercise (Goebel et al., 2000), color-
word interference tasks, mirror tracing tasks (Owen and Steptoe, 2003) and academic 
examination (Maes et al., 1998).   
In addition to an increase in IL-6 in response to an acute laboratory stressor, 
chronic naturalistic stressors also influence cytokine and APP production.  One such 
stressor is socioeconomic status (SES), an indicator of social position.  This construct 
describes types and amounts of resources to which a person has access, both tangible 
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(e.g. wealth) and intangible (e.g. knowledge and social support).  The most common 
ways to measure SES is through highest level of education attained, amount of income, 
occupational status, or a combination of the three (Adler & Snibbe, 2003).  Researchers 
have demonstrated that people of lower SES experience more life stressors, especially 
those stressors associated with a loss of income or ill health.  In addition, those stressors 
have a greater impact on their emotional well-being, compared to individuals of higher 
SES (Kessler, 1979; McLeod & Kessler, 1990).  
A substantial amount of research has demonstrated a strong negative relationship 
between SES and health, in prevalence of chronic diseases (including osteoarthritis, 
hypertension, cervical cancer and cardiovascular disease) as well as mortality rates (Adler 
et al., 1994).  Lower SES has also been associated with higher levels of CRP.  Owen et 
al. (2003) demonstrated an association between occupational status and CRP that was 
independent of age, sex, body mass, waist-to-hip ratio, smoking, alcohol use, and season 
of the year.  A similar finding was recently reported when using education as a measure 
of SES (McDade, Hawkley, & Cacioppo, 2006).  In addition, Brydon et al. (2004) found 
that  individuals exposed to the chronic stressor of living at a low SES show greater 
increases in IL-6 production when they are exposed to a laboratory stressor, compared to 
those of a higher SES (Brydon et al., 2004).   
The evidence that stress activates the inflammatory response is convincing when 
stress is defined as a stimulus.   In this sense, when people are exposed to stress, their 
bodies respond by increasing chemicals such as cytokines and APPs, which are 
responsible for inflammation.  However, as mentioned, defining stress as a stressor is 
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only one of the ways in which people have examined the construct.  The psychological 
reaction or mental state that is the response to the stimulus must also be considered. 
Stress as a psychological experience.  The other definition of stress is that of the 
reaction to a stimulus.  This implies that stress is an internal condition that may vary from 
person to person (Hobfoll, 1989).  Again, the effects that this stress has on a person may 
be what are of interest in a particular study.  However, this time it is the effect of the 
mental state that is the result of the stimuli.  This form of stress is not as objective, 
making it more difficult to measure and understand.  Researchers who study this form of 
stress focus on the psychological condition of a person during or after exposure to a 
stressor.  In this sense stress is an experience that is due to a stimulus, or stressor.  
However, the stressor is not the stress, the experience is the stress.  This type of stress is 
usually studied with the use of self-report questionnaires which question the participant 
about their state of mind and the psychological effects of a stimulus or stimuli.  To make 
a clear distinction between this form of stress and stressors, stress that is the internal 
experience of a stimulus will be referred to as psychological stress. 
Just as stressors have been associated with increases in the inflammatory 
response, studies examining psychological stress produce similar results.  Research has 
shown that those who report severe psychological stress also have significantly higher 
levels of CRP (Hapuarachchi et al., 2003), TNF-α, and IL-6 (Maes et al., 1998) compared 
to those who report normal levels of psychological stress.  Hapuarachchi, Chalmers, 
Winefiled, and Blake-Mortimer (2003) asked healthy volunteers to complete the General 
Health Questionnaire (GHQ) to indicate how much psychological stress they experienced 
over the previous two weeks.  Within two days of the completion of the GHQ they 
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reported to the laboratory to allow for collection of a blood sample from which CRP 
concentrations were measured.  Statistical analyses indicated that those who received 
GHQ scores of 0-1 (normal, little to no stress) had significantly lower CRP 
concentrations compared to those who received scores of 4 or greater (severely stressed).  
In a similar study, Maes et al. (1998) collected samples of blood and asked students to 
complete the Perceived Stress Scale (PSS) more than one month before and after an exam 
as well as one day before the exam.  Their data indicate that when more psychological 
stress was perceived, higher concentrations of IL-6 and TNF-α were present (Maes et al., 
1998).  These results suggest a psychological component that is an important part of the 
inflammatory response.    
Some researchers have explored specific conditions that result due to exposure to 
stressors.  Burnout is a condition associated with emotional exhaustion, depersonalization 
and diminished personal accomplishment caused by long-term exposure to stress.  This 
condition is associated with increased levels of TNF-α (Grossi, Perski, Evengard, 
Blomkvist, & Orth-Gomer, 2003) and CRP in women (Toker, Shirom, Shapira, Berliner, 
& Melamed, 2005).  In addition, Tel Aviv women who report a  state of fear induced by 
periodic terrorist attacks also show a positive relationship between the fear of terror (a 
type of psychological stress) and CRP level (Melamed, Shirom, Toker, Berliner, & 
Shapira, 2004).  Also, individuals with post-traumatic stress disorder, a psychological 
state that is the result of a traumatic stressor, exhibit higher levels of IL-6 (Maes et al., 
1999).   
 Depression can also be a mental state that results from exposure to a stressor, thus 
it can be considered a form of psychological stress.  Depression is characterized by 
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episodes during which an individual experiences a depressed mood or loss of interest or 
pleasure in nearly all activities.  Other depressive symptoms include a significant change 
in weight, sleep, psychomotor activity, or loss of energy, feelings of worthlessness, 
inability to concentrate, or recurrent thoughts of death.  These symptoms often result in 
clinically significant distress or impairment in important areas of functioning (American 
Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, IV – text 
revision, 2000).   
Many studies have found that females who experience a stressful life event are 
more likely to have a depressive episode (Kendler, Karkowski, & Prescott, 1999).  
Kendler, Karkowski, & Prescott (1998) report that many stressful life events (11 of the 15 
they studied) are associated with the onset of major depression (MD) in the month in 
which they occurred.  This association indicates a link between the stimulus (stressor) 
and reaction to the stimulus (MD).  They also found that the severity of the event was 
positively associated with onset of MD, indicating that the more stressful the person finds 
the event; the more likely they are to experience psychological stress.   
A similar line of evidence suggests that a lack of resources creates stress in a 
person’s life and also increases depressive symptoms.  Hobfoll’s (1989) Conservation of 
Resources model defines a resource as anything that is valued by an individual.  A 
resource may be an object (e.g., car or house), condition (e.g., marriage or tenure), 
personal characteristic (e.g., self-esteem), or energy (e.g., time or knowledge).  He goes 
on to explain stress as a reaction to the loss of resources, a threat to the loss of resources, 
or the inability to gain resources after they have been depleted.  Researchers have studied 
this type of stress in relation to depressive symptoms.  Resource loss has been associated 
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with an increase in depressive symptoms while resources gain has been associated with a 
decrease in depressive symptoms.  It has also been observed that a change in resources 
mediates the relationship between negative life events and depressive symptoms 
(Holahan, Moos, Holahan, & Cronkite, 1999).  Therefore, the lack of resources can be 
viewed as an experience of stress which is also manifested in depressive symptoms.   
Depression has also been associated with increases in cytokines and APPs (e.g., 
Miller, Stetler, Carney, Freedland, & Banks, 2002; Owen & Steptoe, 2003; Suarez, 
Krishnan, & Lewis, 2003), although the results are not always consistent.  One study did 
not find significantly higher CRP levels in depressed patients compared to non-depressed 
controls, although they did identify a difference in TNF-α levels (Tuglu, Kara, Caliyurt, 
Vardar, & Abay, 2003).  Danner, Kasl, Abramson, and Vaccarino (2003) found that men 
with a history of a depressive episode were twice as likely to have high levels of CRP 
compared to men with no history of a depressive episode and that more recent episodes 
were associated with a greater likelihood of increased CRP levels.  Interestingly this same 
relationship was not found in females, they hypothesize that this may be because of 
possible protective effects of estrogen or because CRP levels tend to be higher in even 
non-depressed women, making a difference difficult to observe.   
Other studies have found that pharmacological treatment for depression resulted 
in significantly decreased inflammatory markers (Lanquillon, Krieg, Bening-Abu-Shach, 
& Vedder, 2000; Tuglu et al., 2003).  Decreases in CRP levels after antidepressant 
treatment are consistently identified (Lanquillon et al., 2000; Tuglu et al., 2003).  In 
addition, Tuglu et al. (2003) found decreases in TNF-α levels.  However, Lanquillon et 
al. (2000) only found decreases in TNF-α levels in those patients who also exhibited less 
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depressive symptomatology.   While IL-6 levels have not shown a significant post-
treatment decrease, there is evidence that patients who will respond to treatment have 
significantly lower IL-6 levels pre-treatment compared to those who will not respond to 
treatment (Lanquillon et al., 2000).  Perhaps this indicates that those who have more 
prolonged depression (or stress) show higher levels of this cytokine. 
These data support the notion that the psychological experience of a stressor, 
manifested in conditions such as burnout and depression, is related to the inflammatory 
response.  There is also evidence that when stress is defined in terms of the stressor, 
inflammatory cytokines and APPs are also increased.  These inflammatory responses to 
stress may be the link between stress and diseases such as atherosclerosis, which is now 
thought to be an inflammatory disease (Heinz et al., 2003).  Understanding the 
physiological repercussions of stress may allow for the prevention of such diseases. 
Obesity and Inflammation 
 Another factor that influences the inflammatory system is adiposity, the 
accumulation of adipose, or fat, tissue.  Obesity, an excess of adipose tissue, is associated 
with a number of diseases including hypertension, hypercholesterolemia, diabetes, 
coronary heart disease, and some types of cancer (Burton et al., 1985).  Further, obesity is 
becoming an epidemic in the United States.  Between the years 2001 and 2002, it was 
estimated that 65.7% of American adults were overweight or obese and that 30.6% were 
obese.  In addition, overweight and obesity in children during that time period was 
estimated to be 31.5% (Hedley et al., 2004).  The pervasiveness of obesity is dramatically 
increasing.  Among American adults there has been a 50% increase in prevalence in each 
of the past two decades.  A similar pattern is seen in the nation’s children with the 
12 
prevalence of overweight tripling in just twenty years (Wyatt, Winters & Dubbert, 2006).  
Increased body fat has been associated with hyperinsulinemia, diabetes, increased lipid 
levels, hypertension, gallbladder disease, and some forms of cancer (Burton et al., 1985; 
Hartz, Rupley, & Rimm, 1984; Ohlson et al., 1985).  The prevalence of obesity and its 
associated complications highlight the need for further research into the condition.   
Historically, adipose tissue was considered to be only an energy store.  In recent 
years, however, it is becoming apparent that adipose tissue is an active organ of the body 
(Kershaw & Flier, 2004).  The endocrine properties of adipose tissue are becoming less 
ambiguous.  Research indicates that it is capable of secreting many chemicals which have 
effects throughout the body, including proinflammatory cytokines and APPs (Calabro, 
Chang, Willerson, & Yeh, 2005; Lemieux et al., 2001; Mohamed-Ali et al., 1997; 
Mohamed-Ali, Pinkney, & Coppack, 1998; Owen & Steptoe, 2003; Visser, Bouter, 
McQuillan, Wener, & Harris, 1999; Yudkin, Stehouwer, Emeis, & Coppack, 1999).  
Understanding the actions of adipose tissue may provide insight into the connections 
between obesity and the diseases with which it is associated. 
 Numerous researchers have observed increased levels of cytokines and APPs with 
increased adiposity, measured by body mass index, waist-to-hip ratio, and similar 
procedures (Kern et al., 1995; Lemieux et al., 2001; Mohamed-Ali et al., 1997; Owen & 
Steptoe, 2003; Visser et al., 1999; Yudkin et al., 1999).  One study found that obese 
women had significantly higher concentrations of IL-6 and TNF-α, compared to normal 
weight women.  A weight-loss of at least 10% was also associated with a reduction in the 
cytokine levels (Ziccardi et al. 2002).   
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In addition to these correlational observations, in vivo and in vitro studies have 
been able to demonstrate the secretions of the tissue directly.  For example, TNF-α 
production by adipose tissue and adipocytes has been demonstrated in vitro.  Adipose 
tissue biopsies from the abdomens of 37 lean and obese premenopausal females and were 
tested for the presence of TNF-α mRNA and TNF-α protein.  The results of this study, as 
well another that used a similar method, confirmed the presence of TNF-α mRNA in the 
adipose tissue of all volunteers (Hotamisligil, Arner, Caro, Atkinson, & Spiegleman, 
1995; Kern et al., 1995).  In addition, it was demonstrated that the adipose tissue of obese 
individuals expressed more than double the amount of TNF-α mRNA as lean controls.  
All tissue secreted the TNF-α protein and the tissue of obese individuals secreted more 
than that of lean individuals.  Weight-loss resulted in a decrease of TNF-α (Hotamisligil 
et al., 1995) and TNF-α mRNA (Hotamisligil et al., 1995; Kern et al., 1995) in most of 
the obese individuals.  This indication that adipose tissue of obese individuals produces 
excess TNF-α has increased our understanding of the role of obesity in health problems 
such as insulin resistance (Wellen & Hotamisligil, 2005).    
Similar to the stress literature, studies of the production of cytokines by adipose 
tissue do not always result in consistent findings.  One in vivo study measured the 
differences between artery and vein concentrations of IL-6 and TNF-α across 
subcutaneous adipose tissue.  It was discovered that the concentration of IL-6 in venous 
samples, leaving the adipose tissue,  were more than twice as high as the arterial samples, 
entering the adipose tissue.  These results support the hypothesis that IL-6 is produced by 
adipose tissue.  It was also estimated that approximately 30% of the IL-6 circulating in 
the body is secreted by adipose tissue.  This same study found no arterio-venous 
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differences in TNF-α concentration (Mohamed-Ali et al., 1997). Although it is still 
believed that both IL-6 and TNF-α are produced by adipose tissue, these data indicate 
that they may be produced by different depots of adipose tissue at different locations in 
the body.  IL-6 is produced by the abdominal subcutaneous fat depot that was examined 
in this particular experiment, however TNF-α may be produced by another depot 
(Mohamed-Ali et al., 1997).    
 The production of CRP by adipose tissue has also been demonstrated in vitro 
(Calabro et al., 2005; Ouchi et al., 2003).  Human adipocytes incubated for 24 hours with 
IL-1-β and IL-6 produced about twice the amount of CRP as cells that were not 
stimulated.  Cells incubated with adiponectin and leptin did not produce CRP.  These data 
support the role of inflammatory cytokines in the initiation of production of CRP in 
human adipose tissue.  Furthermore, treatment with anti-inflammatory drugs, such as 
aspirin, decreased the amount of CRP produced by the adipocytes, indicating a possible 
pharmacological modulator of CRP production (Calabro et al., 2005). 
   This evidence supports the concept that adipose tissue is not a passive energy 
storage center, but an active organ.  Adipose tissue is responsible for the secretion of 
chemicals that influence the body’s inflammatory process.  There is substantial evidence 
that adipose tissue is a source of the proinflammatory cytokines, IL-6 and TNF-α, as well 
as the acute phase protein, CRP.  However, studies have shown that not all fat depots 
secrete the same cytokines.  The secretions of adipose tissue vary depending on the 
location of the tissue (Fried, Bunkin, & Greenburg, 1998; Mohamed-Ali et al., 1997).  
The differing secretions of the tissue help to explain why central adiposity has been 
shown to be a better predictor of cardiovascular disease, premature death, stroke, and 
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ovarian cancer than overall obesity (Bjorntorp, 1988).  One study even suggested that 
visceral adipose tissue is detrimental to health whereas adipose tissue stored on the hips 
may be beneficial to health (Yusef et al., 2005).  The strong associations between central 
adiposity and illness make it likely that more inflammatory markers are produced in 
central adipose tissue than in adiposity tissue located in other regions.  Continuing to 
study the function of adiposity and its location with respect to inflammation is important 
in understanding the role of obesity in inflammatory disease. 
An Integrated Model of Stress and Obesity’s Effect on Inflammation 
There is a significant amount of research to suggest that psychological stress 
contributes to the inflammatory process.  The result of this relationship is the increased 
levels of cytokines and acute phase proteins during times of stress.  This is evident in that 
IL-6, TNF-α, and CRP are all associated with both the acute phase response and reactions 
to stress.  These chemicals serve to protect and heal the body when faced with an 
infection.  However, in excess they result in chronic diseases such as type 2 diabetes 
(Pradhan, Manson, Rifai, Buring, & Ridker, 2001), metabolic syndrome X (Black, 2003), 
atherosclerosis (Libby, Ridker, & Maseri, 2002), and cardiovascular disease (Black & 
Garbutt, 2002).    
 Obesity is a growing epidemic in the United States and it is important to 
understand both the causes and effects of obesity (Wyatt et al., 2006).  The implications 
of obesity are becoming greater as we learn more about the role of adipose tissue as an 
active endocrine organ, secreting chemicals that influence all parts of the body.  There is 
sufficient evidence that adipose tissue is responsible for some of the body’s production of 
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cytokines and acute phase proteins (e.g., Calabro et al., 2005; Mohamed-Ali et al., 1997; 
Ouchi et al., 2003). 
 The relationships between stress and cytokine/APP increases and adipose tissue 
and cytokine/APP production have led to the proposal of a new model.  It is known that 
stress is associated with the release of cytokines and APPs and that adipose tissue is one 
source of these chemicals.  The proposed model combines this information to suggest that 
stress acts at the level of the adipose tissue to increase the secretion of these chemicals.  
The new model suggests that stress promotes the release of inflammatory markers from 
adipose tissue.  Stress may act on or interact with the adipose tissue to result in the 
release of more cytokines and APPs than are produced under normal circumstances.  
 The proposed model is based on the research indicating that adipose tissue 
produces cytokines and APPs.  The body needs a certain level of these chemicals to 
protect itself from injury and infection, so the adipose tissue may be constantly secreting 
the inflammatory markers.  However, if there is too much adipose tissue, there are more 
secretion sites, which lead to an abundance of the markers.  Another line of research 
suggests that stress is associated with an increase in inflammatory markers.  The 
proposed model suggests that this increase in inflammatory markers may be due to stress 
causing the adipose tissue to secrete more cytokines and APPs than it would under 
normal circumstances.  Therefore, the new model posits that the relationship between 
stress and inflammation is moderated by adiposity.  Stress increases the release of 
cytokines and APPs from adipose tissue, when there is a lot of adipose tissue there will 
be many secretion sites and more cytokines will be released.  Thus, the effect that stress 
has on inflammation is dependent on the amount of adipose tissue that is present.  This 
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interaction between stress and adipose tissue may help to explain their relationships to 
disease.   
This model proposes a potential mechanism through which obesity and stress lead 
to diabetes, atherosclerosis, and other cardiovascular diseases.  If the mechanism can be 
better understood, more treatment options may become available.  Reducing the body’s 
supply of cytokines and APPs is complicated because there is a level that is necessary to 
fight infection. Researchers have begun to focus on the possibility that drugs may be used 
to control levels of inflammatory cytokines.  Studies indicate that non-steroidal anti-
inflammatory drugs, such as ibuprofen, can prevent monocytes from producing 
inflammatory cytokines (Jiang, Ting, & Seed, 1998).  However, it is possible that these 
drugs may decrease the cytokines to a dangerously low level which will inhibit the 
body’s ability to fight infection (Yudkin, Kumari, Humphries, & Mohamed-Ali, 2000).  
The proposed model suggests that the body is at homeostasis when the correct amount of 
adipose tissue is present and there is no stress.  Therefore, when inflammation is at a high 
level, decreasing the amount of adipose tissue or stress may enable an individual to 
achieve homeostasis safely. 
Previous studies have focused on the differences between obese and non-obese 
participants or the impact of stress compared to lack of stress in participants.  A study 
that combines these two areas of research will aid in the determination of the validity of 
this model.   The model predicts that because lean people have less adipose tissue to 
secrete cytokines and APPs, they will not produce as many of these chemicals, even 
when faced with stress.  Conversely, those that are obese have more adipose tissue to 
secrete the inflammatory cytokines and APPs.  When obese people are faced with stress 
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they will show a more dramatic increase in cytokines and APPs due to their greater 
number of production sites (adipose cells).    These explorations would help to determine 
the legitimacy of this model as well as further our understanding of the effects of stress 
and obesity on health.   
While limited experimental information is available concerning the direct 
relationships between stress, adiposity and inflammation, there is some evidence of the 
interactions.   For example, some researchers have found that measures of adiposity 
reduce or negate the association between stress (and depression) and cytokines and/or 
APPs.  The indication that significant associations between stress and inflammation 
become insignificant after adjusting for adiposity may indicate that adiposity moderates 
the stress/inflammation relationship (Douglas, Taylor, & O’Malley, 2004; Miller et al., 
2002). These data have led Miller and colleagues to demonstrate a mediator model in 
which depression promotes accumulation of adipose tissue and the adipose tissue causes 
inflammation directly by releasing cytokines as well as indirectly through the release of 
leptin which stimulates the production of cytokines (Miller, Freedland, Carney, Stetler, & 
Banks, 2003).  This type of model does not account for the inflammatory effects of 
depression that are independent of adiposity.  A moderator model may be able to better 
explain this relationship.  It is also limited to the effects of depression and not stress in 
general.   
A similar model was tested by Ladwig, Marten-Mittag, Lowel, Doring, and 
Koenig (2003) in a German, population-based sample of 3205 men ages 45-74.  They 
found increased CRP concentrations in obese, compared to non-obese men.  Also, CRP 
and BMI were significantly correlated.  They also found that depressive mood was 
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associated with high CRP concentrations in obese, but not non-obese, participants.  An 
ANOVA revealed significant main effects for BMI and a depressive mood as well as a 
depressed mood x BMI interaction.  This study indicates the importance of examining the 
combined effects of adiposity and depression on inflammation.  Interestingly, there have 
been very few studies to examine the interactions between stress and adiposity on 
inflammation, producing no strong conclusions (McDade et al., 2006). 
Present Study 
The goal of this study is to replicate previous findings of the relationships 
between stress, obesity and inflammation.  In addition, this study will test the integrated 
model by examining a possible interaction between the effects of stress and obesity on 
inflammation.  The APP, CRP will be used as a measure of inflammation.  This protein 
has been identified as one of the most useful in predicting future cardiovascular disease 
(Albert, Ma, Rifai, Stampfer, & Ridker, 2002; Pearson et al., 2003; Ridker, Cushman, 
Stampfer, Tracy, & Hennekens, 1997; Ridker, Hennekens, Buring, & Rifai, 2000).  High 
levels of CRP are associated with risk for coronary heart disease that is 1.7 times the risk 
for those with lower levels of CRP (Danesh, Collins, Appleby, & Peto, 1998).  Therefore, 
it is important to gain better understanding of the factors that increase the levels of the 
APP.  CRP has also been associated with both stress (e.g. Hapuarachchi et al., 2003; 
Melamed et al., 2004; Owen et al., 2003) and obesity (e.g. Lemieux et al., 2001; Visser et 
al., 1999; Yudkin et al., 1999).   
To gain a comprehensive understanding of the effects of stress, measures of 
stressors and psychological stress will be examined.  Socioeconomic Status (SES) will be 
used to examine the effect that this type of stressor has on the inflammatory marker, 
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CRP.  In addition, depression will be employed to examine the role that psychological 
reactions to stressors have on CRP.  This will add to the evidence that Ladwig et al. 
(2003) and Miller et al. (2003) presented with regard to only depression.  A review of the 
literature has not resulted in a study that has examined the interactions of SES and 
adiposity on inflammation. 
This study will also examine the association between adiposity and inflammation.  
A previous study on the interaction of obesity and depression focused only on BMI 
(Ladwig et al., 2003).  However, recent literature has indicated that the location of 
adiposity may be more important than how much there is (Yusef et al., 2005).  In 
addition, in Miller et al.’s (2002) study of depressed and non-depressed participants, they 
did not identify an association of waist-to-hip ratio and CRP but did find an association 
between BMI and CRP.  More research is needed to provide a better understanding the 
effects of adiposity and distribution of adiposity.  Therefore, in addition to looking at the 
relationship between BMI and inflammation, this study will also examine the effects of 
central adiposity, measured via waist circumference (WC), which will provide a more 
complete picture of the types of adiposity that are associated with the detrimental effects 
of stress and inflammation.   
In addition, this study will include both men and women from a population-based 
sample in the United States.  Ladwig et al.’s (2003) study of German men may not be 
generalizable to the entire US population.  In addition, Danner et al. (2003) found that 
depression in men, but not women, was associated with increased levels of CRP.  This 
indicates that the interactions of adiposity and stress may be different in men and women.  
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Both genders will be studied in order to develop a more complete understanding of this 
model.   
Recent research has dramatically changed our understanding of the physiology of 
the body.  We are now aware of the relationship between the stress response and the 
inflammatory process.  It is becoming clear that stress causes an increase in the 
concentrations of cytokines and acute phase proteins associated with inflammation.  We 
are also learning more about the endocrine properties of adipose tissue and there is 
evidence to support the production of cytokines and APPs by adipose tissue.  The 
proposed model joins these two quickly progressing areas of research.  It suggests that if 
stress causes the increase in certain biochemicals, and those biochemicals are produced 
by adipose tissue, stress may cause an increase in the adipose tissue’s production of those 
chemicals.  This model may provide a better understanding of how stress and obesity 
interact and cause serious, often deadly, diseases.   
 This study will test three main hypotheses in order to demonstrate the 
relationships between stress, adiposity, and inflammation.  The first hypothesis is that 
stress will be positively related to inflammation.  Stress will be defined as both a stressor 
(SES) and as psychological stress (depression).  An increase in stress is expected to be 
associated with an increase in inflammatory markers (CRP).  The second hypothesis is 
that adiposity will be positively related to inflammation.  Total body mass (BMI) as well 
as central adiposity (WC) will be used to measure adiposity.  An increase in adiposity is 
expected to be associated with an increase in inflammation (CRP concentration).  The 
third hypothesis states that there will be an interaction between stress and adiposity.  
Adiposity is expected to moderate the association between stress and inflammation. 
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Method 
 This study utilized the data resulting from the National Health and Nutrition 
Examination Survey (NHANES).  The survey was conducted by the National Center for 
Health Statistics division of the Centers for Disease Control (CDC) to obtain health, diet 
and nutrition information from a nationally representative sample.   The current version 
of the NHANES survey began in 1999.  The data were compiled and released in two-year 
increments; this study involved the analysis of the 2003-2004 data release.  The data are 
available to the public and are accessed via the CDC’s website (National Center for 
Health Statistics, 2006).   
Participants 
 NHANES utilized a complex, stratified random sampling procedure to obtain a 
sample of participants that is representative of the civilian, non-institutionalized 
population of the United States.  The sampling procedure first sampled counties (or 
groups of small counties) in the United States.  Within the counties, segments (blocks or 
clusters of households) were sampled and from each segment, households were selected.  
One or more member of each household sampled was asked to participate in the study.  
Participants were compensated for their time and reimbursed for the cost of transportation 
and childcare (National Center for Health Statistics, 2006).   
Included in the dataset were 4998 adults who participated in the household 
interview and medical examination.  The sample was comprised of 48% (N = 2416) 
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males and 52% (N = 2582) females ranging in age from 18 years to over 85 years (M = 
47.13, SD = 20.86).  Mexican Americans, African Americans, low-income individuals, 
and the elderly were over-sampled.  However, the CDC provided sampling weights 
which were used to correct for the over-sampling and ensure that the data can be 
generalized to the U.S. population (National Center for Health Statistics, 2006).   
A subsample was chosen to participate in the Major Depression module of the 
Composite International Diagnostic Interview (CDCI)1.  Participants eligible for this 
subsample were those who spoke English or Spanish and were between the ages of 20 
and 39 (M = 28.97, SD = 5.74).  The depression subsample consisted of 589 participants 
(294 male and 295 female).   Analysis of the subsample utilized sampling weights to 
ensure that the subsample is also representative of the U.S. population (National Center 
for Health Statistics, 2006).   
Materials 
 Stressor.  The stressor that was measured was socioeconomic status (SES).  As 
previously mentioned, this is an indicator of social position, which is often quantified 
through education, income, and occupation.  Because occupational status is subjective 
and hard to quantify in the U.S., studies examining the relationship between SES and 
health often rely on measures of income and/or education to assess SES (Gallo & 
                                                 
1
 This small subsample allowed for the analysis of psychological stress, operationalized 
as depression.  However, there was a concern that the restricted age range may limit the 
external validity of the study and may not allow for enough variability in CRP to 
demonstrate a clear relationship.  Therefore, the larger sample was the primary sample 
used for the analyses not requiring the measurement of depression or depressive 
symptoms.   
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Matthews, 2003). Therefore, the effects of income and education on inflammation were 
each explored. 
 The income variable was based on the participant’s annual household income.  
There were 13 categories from which the participants was asked to select which best 
describes his/her household income.  The categories were divided into five $5,000 ranges 
between $0 and $24,999 and five $10,000 ranges between $25,000 and $74,999.  They 
were also given the options of “$75,000 and over,” “Over $20,000,” and “Under 
$20,000” (National Center for Health Statistics, 2006).   There is an inverse relationship 
between income level and the amount of stressors in a person’s life (Kessler, 1979; 
McLeod & Kessler, 1990).   
 Participants were also asked to indicate the highest grade or level of school that 
they have completed or the highest degree that they have received.  The answers were 
then coded as “Less than High School,” “High School Diploma (including GED),” or 
“More than High School” (National Center for Health Statistics, 2006).  There is an 
inverse relationship between the amount of education received and the amount of 
stressors a person experiences (Kessler, 1979; McLeod & Kessler, 1990).   
 Psychological stress.  Depressive symptoms were measured to indicate the level 
of psychological stress. The Depression Module of an automated version of the 
Composite International Diagnostic Interview (CIDI) was used to assess depressive 
symptoms and to provide a diagnosis of Major Depressive Disorder (MDD).  The CIDI 
was designed by the World Health Organization to diagnose mental illness according to 
the criteria of the 10th edition of the International Classification of Diseases (ICD-10) and 
the 4th edition of the Diagnostic and Statistics Manual of Mental Disorders (DSM-IV).   
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The CIDI is a structured interview designed to be used by lay people collecting data in 
epidemiological studies.  The items assess the presence of each of the criteria for MDD 
over the past 12 months.  The participant was asked if there was a period of two weeks or 
longer during which they felt “sad or depressed or empty” or during which they “lost 
interest in most things.”  The items also addressed symptoms of MDD, such as appetite 
change, insomnia/hypersomnia, reduced psychomotor activity, feelings of worthlessness, 
inability to concentrate, or recurrent thoughts of death.  The interview resulted in a 
diagnosis as well as information to assess the severity of the disorder.  The module was 
administered during a face-to-face interview at the Mobile Examination Center (MEC) 
during which the interviewer asked each question (in either Spanish or English) as it 
appeared on a computer screen and entered the answers into a personal computer.  The 
scores were provided as a quantity of depressive symptoms (0-9) as well as a 
dichotomous variable indicating whether or not criteria for Major Depressive Disorder 
were met (National Center for Health Statistics, 2006).   
 Adiposity.  Adiposity was measured using both body mass index (BMI) and waist 
circumference (WC).  BMI is a measure of total body mass that is calculated by dividing 
the total body weight (in kilograms) by height (in meters) squared.  These measurements 
were conducted by a health technician at the MEC.   Weight was measured and recorded 
when the participant stepped onto a digital scale that was connected to the Integrated 
Survey Information System (ISIS system), which automatically stored the data.  
Participants were weighed wearing only underwear, a disposable paper gown, and foam 
slippers.   Height was measured with an electronic stadiometer that was also connected to 
the ISIS system.  The participant was instructed to stand straight against a vertical board, 
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with relaxed arms and shoulders, both feet together and toes pointed out at an angle of 
approximately 60°.   The headboard was then lowered to the top of the participant’s head 
and the height was sent to the ISIS (National Center for Health Statistics, 2006).   
WC is a measure of central adiposity and was measured with a metal tape which 
is placed around the participant’s torso at the level of the right ilium.   This measurement 
was also conducted at the MEC by a trained health technician.  All measurements were 
made to the nearest 0.1 cm (National Center for Health Statistics, 2006).   
 Inflammation.  Blood CRP concentration was used to measure inflammation. 
Venipuncture was performed by a certified phlebotomist at the MEC. The phlebotomist 
collected 89 to 92 ml of blood from the participant’s arm.  The blood was processed, 
stored and shipped to the University of Washington to be processed using latex-enhanced 
nephelometry.  A Behring Nephelometer was used to obtain the concentration of CRP in 
the sample of blood (National Center for Health Statistics, 2006).   
Procedure 
 Households that were selected to participate in the study were sent a brochure 
describing the study’s purpose and procedures.  A trained interviewer then visited each 
household and conducted a screening interview to determine if any occupants of the 
household were eligible for the study.  Once the eligible occupants were identified, they 
were asked to participate and provided informed consent.  Each participant then 
completed the household interview to obtain demographic information, including 
information regarding SES.  At the conclusion of the home interview the interviewer 
scheduled an appointment for the participant at the MEC (National Center for Health 
Statistics, 2006).    
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The MEC is comprised of four large trailers that were designed for the NHANES 
survey and are equipped to perform extensive medical testing.  When the participant 
reported to the MEC, the measures of adiposity were performed and blood was drawn to 
determine CRP level.  The subset of participants who were selected to undergo mental 
health testing also completed the CIDI during this visit to the MEC (National Center for 
Health Statistics, 2006).   
 The data were then compiled and posted on the CDC’s website to be made 
available to the public (National Center for Health Statistics, 2006).   
Data Analysis 
 The NHANES survey used a complex, stratified sampling procedure to produce a 
sample that is representative of the non-institutionalized civilian population of the United 
States.  To   achieve this representation, each participant’s data was weighted. Analyses 
that incorporate these weights allow for an estimate of the data that would result if the 
entire non-institutionalized civilian population of the U.S. were sampled (National Center 
for Health Statistics, 2006).  The data were analyzed with and without the sample weights 
and the results were similar.  The unweighted analyses will be presented in the results 
section (see Appendix A for summaries of the weighted analyses).   
The primary goal of the study was to test the proposed model which suggests that 
stress interacts with adipose tissue to increase the production of inflammatory cytokines 
and APPs.  There were three primary hypotheses: (1) stress variables 
(income/education/depression diagnosis/depression symptoms) will be positively related 
to the inflammatory marker, CRP, (2) adiposity variables (BMI/WC) will be positively 
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related to CRP, and (3) there will be an interaction between stress variables and adiposity 
variables.   
To test the hypotheses, eight (4 stress variables x 2 adiposity variables) 
hierarchical multiple regression analyses were conducted.  Other factors which affect 
CRP levels, including gender, age, race, use of blood pressure medication, use of 
cholesterol medication, and smoking status, were statistically controlled to eliminate 
these constructs as possible confounding variables, increasing confidence in the 
conclusion that stress and adiposity are related to increased CRP levels2.   
The covariates were entered into the model in step one.  To test Hypotheses 1 and 
2, the stress variable (income or education or depression measure) and adiposity variable 
(WC or BMI) were entered at step two.  Hypothesis 3 was tested at step three when the 
interaction between the adiposity and stress variable was added to the model.  When a 
statistically significant interaction between a stress variable and an adiposity variable was 
detected, regression lines were plotted as described by Preacher (2003) to demonstrate 
the nature of the interaction.   
Previous research has indicated that the relationship between depression and 
inflammation may differ by gender (Danner et al., 2003).  Therefore, further analyses 
were conducted to test the moderating effect of gender on the relationships between stress 
and adiposity and inflammation.  To explore this possibility, hierarchical regressions 
were conducted in which the covariates (age, race, use of blood pressure medication, use 
                                                 
2
 Because race and SES may be related, there was a concern that controlling for race 
would restrict the range of the SES variable.  Therefore, the analyses were also conducted 
excluding race as a covariate.  However, the exclusion of race variables produced a 
similar pattern of results.  Race is included in all analyses reported. 
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of cholesterol medication, and smoking status) were entered in step one, the stress 
variable, adiposity variable, and gender were entered at step two, the two way 
interactions were added to the model in step three and in step four a three way interaction 
between gender, stress, and adiposity was entered.   
To further examine the two-way interactions between gender and stress variables 
and gender and adiposity variables, specific analyses were conducted to examine the role 
of gender.  To explore the moderating effect of gender on the relationship between the 
stress variables and CRP, a hierarchical regression was conducted in which all of the 
covariates mentioned above and the adiposity variables were entered into step one.  In 
step two, gender and the stress variable were entered and in step three the interaction 
between gender and the stress variable was entered into the model.  Similarly, to explore 
the moderating effect of gender on the relationship between adiposity and CRP, a 
hierarchical regression was conducted in which the covariates and stress variables were 
entered into step 1, the gender and adiposity variable was entered into step two and the 
gender x adiposity interaction was entered into step 3.  When a statistically significant 
interaction was detected, regression lines were plotted as described by Preacher (2003).   
A concentration of CRP that is greater than 1 mg/dL (i.e., 10 mg/L) is indicative 
of an inflammatory response to an infection (Pearson et al., 2003).  Therefore, 
participants with a concentration of CRP that was greater than or equal to 1 mg/dL were 
excluded from the analysis (n = 538; 10.78%).  In addition, the distribution of CRP 
concentrations in the sample was positively skewed, necessitating a logarithmic 
transformation of the data, which resulted in a normal distribution.  Therefore, logCRP 
was used in all analyses.   
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The distribution of number of depressive symptoms was also positively skewed, 
with 87.44% of the sample reporting no depression symptoms.  Logarithmic and square 
root transformations were unsuccessful at normalizing the data; therefore raw data were 
used in all analyses.  
Due to the design of NHANES (see above), the sample of participants used for 
the “stressor” (education and income) analyses was not the same as the sample of 
participants used for the “psychological stress” (depression diagnosis and number of 
depression symptoms) analyses.  The sample that was used in the stressor analyses is 
referred to as the SES Sample and the sample that was used in the psychological stress 
analyses is referred to as the Depression Sample.   
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Results 
SES Variables and Adiposity Variables as Predictors of CRP  
 Descriptive statistics.  Means and standard deviations of logCRP, BMI, and WC 
for the SES sample are presented in Table 1.  The participants were distributed across the 
three levels of education: 1348 (30.26%) reported less than a high school education, 1141 
(25.61%) reported having a high school education and 1966 (44.13%) reported having 
received more than a high school education.  They were also distributed across the 
income brackets (see Table 2).   
 
 
Table 1 
Mean Values of Variables in the SES Analyses 
Variable M SD 
logCRP -1.86 1.09 
BMI 27.57 5.72 
WC 95.86 14.80 
Note. logCRP = logarithmic transformation of C-reactive  
protein (mg/dL), BMI = body mass index (kg/m2),  
WC = waist circumference (cm) 
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Table 2 
 
Distribution of Participants Across the Levels of Household Income 
Income Bracket Frequency Percent 
$0 to $4, 999 96 2.32 
$5,000 to $9,999 240 5.81 
$10,000 to $14,999 410 9.92 
$15,000 to $19,999 354 8.57 
$20,000 to $24,999 372 9.01 
$25,000 to $34,999 580 10.94 
$35,000 to $44,999 452 10.94 
$45,000 to $54,999 364 8.81 
$55,000 to $64,999 235 5.69 
$65,000 to $74,999 203 4.91 
$75, 000 and over 825 19.97 
Note.  329 participants did not have data regarding household income                           
 
 Correlations.  Pearson correlation coefficients indicate significant positive 
relationships between logCRP and the adiposity variables and negative relationships 
between logCRP and the stress variables (i.e., higher CRP is associated with lower SES).  
In addition, the two adiposity variables and the two stress variables were significantly 
correlated.  However, the stress and adiposity variables were not related to each other 
(See Table 3).   
 
Table 3 
 
Correlations Between Variables in the Socioeconomic Status Analyses 
 Log CRP BMI WC Education Income 
logCRP 1.00 0.420*** 0.438*** -0.059*** -0.076*** 
BMI  1.00 0.879*** -0.027 -0.011 
WC   1.00 -0.028 -0.020 
Education     1.00  0.334*** 
Income     1.00 
Note. logCRP = logarithmic transformation of C-reactive protein (mg/dL),  
BMI = body mass index (kg/m2), WC = waist circumference (cm).  ***p < 0.001 
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 Hierarchical linear regression analyses.  Hierarchical linear regressions were 
conducted to determine the ability of the stress variables (education and income) and the 
adiposity variables (BMI and WC) to predict logCRP.  Tables 4 through 7 summarize the 
results of the four analyses that were conducted.   
The models that included education and BMI, education and WC, income and 
BMI, and income and WC were all statistically significant predictors of logCRP (see 
Tables 4 through 7).   All models supported the first and second hypotheses, indicating 
significant main effects for education, income, BMI, and WC.  In addition, the analyses 
suggested an interaction between education and BMI, education and WC, and income and 
BMI.  All models that included the main effects (i.e., step 2) accounted for a significant 
amount of variance.  Adding significant interaction terms resulted in statistically 
significant increases in R2, though the changes were small (see Tables 4 through 7).    
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Table 4 
Summary of Hierarchical Regression Analysis for Education and BMI Predicting 
LogCRP     
Variable B SE B       β     ∆R2 F(10, 3681) p 
Step 2    0.137*** 93.50 <0.001 
     Education - 0.028 0.020 - 0.023    
     BMI   0.069 0.003   0.381***    
Step 3        0.001*   85.52 <0.001 
     Education - 0.225 0.092 - 0.183*    
     BMI   0.054 0.008   0.296***    
     Education x BMI   0.007 0.003   0.179*    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI 
= body mass index (kg/m2). R2 = 0.066, F (8,3683) = 32.25, p < 0.001 for Step 1; R2 = 0.203 for Step 2; R2 
= 0.204 for Step 3.    
*p < .05, ***p < .001 
 
 
Table 5 
Summary of Hierarchical Regression Analysis for Education and WC Predicting LogCRP     
Variable B SE B       β     ∆R2 F(10, 3621) p 
Step 2    0.161*** 105.36 <0.001 
     Education - 0.025 0.020 - 0.020    
     WC   0.031 0.001   0.426***    
Step 3        0.001*   96.36 <0.001 
     Education - 0.308 0.127 - 0.250*    
     WC   0.024 0.003   0.337***    
     Education x WC   0.003 0.001   0.243*    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  WC 
= waist circumference (cm). R2 = 0.065, F (8, 3623) = 31.38, p < 0.001 for Step 1; R2 = 0.225 for Step 2;   
R2 = 0.227 for Step 3.  *p < .05, ***p < .001 
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Table 6 
Summary of Hierarchical Regression Analysis for Income and BMI Predicting LogCRP        
Variable B SE B       β ∆R2 F(10, 3434) p 
Step 2    0.136*** 86.53 <0.001 
     Income -0.021 0.006 -0.060***    
     BMI 0.069 0.003 0.377***    
Step 3        0.002** 79.75 <0.001 
     Income -0.102 0.027 -0.293***    
     BMI 0.050 0.007 0.272***    
     Income x BMI 0.003 0.001 0.256**      
                                                                       
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI 
= body mass index (kg/m2).  R2 = 0.065, F(8, 3436) = 29.85, p < 0.001 for Step 1; R2 = .201 for Step 2; R2 = 
.204 for Step 3.   
**p < .01, ***p < .001 
 
Table 7 
Summary of Hierarchical Regression Analysis for Income and WC Predicting LogCRP     
Variable B SE B     β     ∆R2 F(10, 3378) p 
Step 2    0.158*** 96.96 <0.001 
     Income -0.018 0.006 -0.050**    
     WC  0.031 0.002  0.421***    
Step 3        0.001   88.51 <0.001 
     Income -0.083 0.037 -0.240*    
     WC  0.026 0.003  0.357***    
     Income x WC  0.001 0.000 0.199    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  WC 
= waist circumference (cm). R2 = 0.065, F (8, 3380) = 29.18, p < 0.001 for Step 1; R2 = 0.223 for Step 2;   
R2 = 0.224 for Step 3.  *p < .05, ***p < .001 
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 Regression lines were plotted to gain a better understanding of the nature of the 
interactions.  Figures 1 and 2 demonstrate the effect of education and income on logCRP 
moderated by BMI.  The regression lines illustrate the simple slopes and simple 
intercepts for normal (BMI = 21.70), overweight (BMI = 27.45), and obese (BMI = 35) 
individuals.  The BMI chosen to represent each group is the median BMI value for each 
category.  Figure 3 illustrates the effect of education on logCRP moderated by WC.  The 
regression lines illustrate the simple slopes and simple intercepts for individuals with 
high (106.7 cm) and low (86.0 cm) WC.  The values of WC chosen represent the 75th and 
25th percentile of WC in the SES sample, respectively.  They are also above/below the 
recommended maximum WC for males (101.6 cm) and females (88.9 cm).   
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Figure 1.  BMI moderates the effect of education on logCRP concentrations.  Values for 
Education: 1 = less than high school; 2 = high school or GED; 3 = more than high school.  
Follow-up analyses indicated that the slope for the normal BMI group was significantly 
different from zero (B = -0.072, t(3680) = -2.540, p < 0.05).  However the slopes for the 
overweight and obese groups were not significantly different from zero (B = -0.032, 
t(3680) = -1.586, p > 0.05; B = 0.021, t(3680) = 0.704, p > 0.05, respectively).   
*slope is significantly different than zero. 
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Figure 2.  BMI moderates the effect of income and BMI on logCRP concentrations.  
Values for Income represent the income brackets described in the methods section: 1 = $0 
to $4, 999; 2 = $5,000 to $9,999; 3 = $10,000 to $14,999; 4 = $15,000 to $19,999; 5 = 
$20,000 to $24,999; 6 = $25,000 to $34,999; 7 = $35,000 to $44,999; 8 = $45,000 to 
$54,999; 9 = $55,000 to $64,999; 10 = $65,000 to $74,999; 11 = $75, 000 and over.  
Follow-up analyses indicated that the slopes for the normal BMI and overweight groups 
were significantly different from zero (B = -0.039, t(3433) = -4.857, p < 0.01; B = -0.023, 
t(3433) = -4.047, p < 0.01, respectively).  However the slope for the obese group was not 
significantly different from zero (B = -0.001, t(3433) = -0.095, p > 0.05).   
*slope is significantly different than zero. 
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Figure 3.  WC moderates the effect of education on logCRP concentrations.  Education 
Values: 1 = less than high school; 2 = high school or GED; 3 = more than high school.  
Follow-up analyses indicated that the slope for the low WC group was significantly 
different from zero (B = -0.061, t(3620) = -2.386, p < 0.05).  However, the slope for high 
WC group was not significantly different from zero (B = -0.002, t(3620) = -0.103, p > 
0.05).   
*slope is significantly different than zero. 
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 It was hypothesized that, when faced with more stress (i.e, lower SES), those with 
more adiposity would demonstrate a greater increase in concentrations of CRP than those 
with less adiposity.   Interestingly, this is not the pattern present in the data (see Figures 1 
– 3).  Across all analyses of the SES sample, the simple slope of the regression line for 
those with the highest adiposity is not significantly different from zero, suggesting no 
effect of education or income on logCRP for this group.  Conversely, those with lower 
adiposity demonstrate the expected negative relationship between education, income and 
logCRP. Thus, the inflammatory marker, CRP, in those with less adiposity appears to be 
more strongly related to the SES variables.    
Depression Variables and Adiposity Variables as Predictors of CRP  
 Descriptive statistics.  Means and standard deviations of logCRP, BMI, WC, and 
number of depression symptoms for the Depression sample are presented in Table 8.  As 
previously mentioned, 87.44% of the participants in this sample reported no symptoms of 
depression.  In addition, 550 (93.38%) of the participants did not meet criteria for major 
depressive disorder.   
 
Table 8 
 
Mean Values of Variables in the Depression Analyses 
Variable M SD 
logCRP -2.00 1.18 
BMI 27.25 6.04 
WC 93.52 15.36 
Depression Symptoms 0.78 2.15 
Note.  logCRP = logarithmic transformation of  C-reactive protein, BMI = body mass index (kg/m2), WC = 
waist circumference (cm) 
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 Correlations.  Pearson correlation coefficients indicate significant positive 
relationships between logCRP and the adiposity variables.  Further, the two adiposity 
variables (BMI and WC) were related to each other as were the two psychological stress 
variables (depression diagnosis and number of depression symptoms).  In addition, there 
was a small positive correlation between number of depression symptoms and BMI (See 
Table 9).    
 
Table 9 
 
Correlations between Variables in the Depression Analyses                       
 Log CRP  BMI   WC Income Education 
Depression 
Diagnosis 
Depression 
Symptoms 
logCRP 1.00 0.438*** 0.428***  -0.079 -0.031 0.061 0.080 
BMI  1.00 0.909*** -0.120** -0.113** 0.048 0.088* 
WC   1.00 -0.064 -0.073 0.024 0.063 
Income      1.00  0.338*** -0.077 -0.079 
Education     1.00 -0.022 -0.003 
Depression Diagnosis    1.00 0.767*** 
Depression Symptoms     1.00 
Note. CRP = logarithmic transformation of C-reactive protein, BMI = body mass index (kg/m2), WC = waist 
circumference (cm).  * p < 0.05, **p < 0.01, ***p < 0.001 
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 Hierarchical linear regression analyses.  Hierarchical linear regressions were 
conducted to determine the ability of the depression indices (depression diagnosis and 
depression symptoms) and the adiposity variables (BMI and WC) to predict logCRP.  
Tables 10 through 13 summarize the results of the four analyses that were conducted 
(depression diagnosis and BMI, depression diagnosis and WC, depression symptoms and 
BMI, and depression symptoms and WC).  These analyses indicate that both BMI and 
WC are significantly related to logCRP. However, neither depression symptoms nor 
depression diagnosis not significantly predicted logCRP in any analysis.  There were also 
no significant interactions between the depression and adiposity variables.    
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Table 10 
Summary of Hierarchical Regression Analysis for Depression Diagnosis and BMI 
Predicting LogCRP          
Variable B SE B     β     ∆R2 F(10, 572) p 
Step 2    0.189*** 21.79 <0.001 
     Depression Diagnosis  0.175 0.171 0.037    
     BMI 0.087 0.007  0.444***    
Step 3        0.000   19.80 <0.001 
     Depression Diagnosis  0.443 0.626  0.094    
     BMI  0.088 0.008  0.450***   
 
     Depression Diagnosis x BMI -0.010 0.021 -0.060   
 
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  
BMI= body mass index (kg/m2).  R2 = 0.087, F (8, 574) = 6.80, p < 0.001 for Step 1; R2 = 0.276 for Step 2; 
R 2= 0.276 for Step 3.  ***p < .001 
 
 
 
Table 11 
 
Summary of Hierarchical Regression Analysis for Depression Diagnosis and WC 
Predicting LogCRP               
Variable B SE B     β     ∆R2 F(10, 568) p 
Step 2    0.201*** 22.72 <0.001 
     Depression Diagnosis 0.206 0.172   0.043    
     WC 0.036 0.003   0.463***    
Step 3        0.000  20.64 <0.001 
     Depression Diagnosis  0.569 0.966   0.119    
     WC  0.036 0.003   0.467***   
 
     Depression Diagnosis x WC   -0.004 0.010 -0.077   
 
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  
WC=Waist Circumference (cm).  R2 = 0.085, F (8, 570) = 6.65, p < 0.001 for Step 1; R2 = 0.286 for Step 2; 
R 2= 0.286 for     Step 3.  ***p < .001 
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Table 12 
Summary of Hierarchical Regression Analysis for Depression Symptoms and BMI 
Predicting LogCRP                                                                                                                                   
Variable B SE B       β    ∆R2 F(10, 572) p 
Step 2    0.189*** 21.79 <0.001 
     Depression Symptoms  0.020 0.020   0.037    
     BMI  0.087 0.007   0.443***    
Step 3        0.000 19.78 <0.001 
     Depression Symptoms  0.010 0.079   0.019    
     BMI 0.086 0.008   0.441***   
 
     Depression Symptoms x BMI 0.0003 0.003   0.019   
 
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.   
BMI = body mass index (kg/m2).  R2 = 0.087, F (8, 574) = 6.80, p < 0.001 for Step 1; R2 = 0.276 for Step 2; 
R 2= 0.276 for Step 3.   ***p < .001 
 
 
Table 13 
 
Summary of Hierarchical Regression Analysis for Depression Symptoms and WC 
Predicting LogCRP     
Variable B SE B     β    ∆R2 F(10, 548) p 
Step 2    0.207*** 22.04 <0.001 
     Depression Symptoms 0.022 0.020 0.041    
     WC 0.036 0.003 0.466***    
Step 3        0.000 20.00 <0.001 
     Depression Symptoms  0.001 0.118 0.002    
     WC 0.035 0.003 0.463***   
 
     Depression Symptoms x WC 0.0002 0.001 0.039   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC = Waist 
Circumference (cm).  R2 = 0.080, F(7, 551) = 6.84, p < .0001 for Step 1; R2 = .287 for Step 2; R2 = .287 for 
Step 3.  ***p < .001. 
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Gender as a Moderator of the relationship between Stress Variables and CRP 
 Analyses were conducted to test the moderating effect of gender on the 
relationships between stress and adiposity and inflammation.  Hierarchical regressions 
were conducted to determine whether there were interactions between the stress 
variables, adiposity variables, and CRP.  The results did not suggest a three-way 
interaction between gender, stress, and adiposity. However, they did indicate that gender 
moderates the effects of the stress variables on levels of CRP and adiposity on levels of 
CRP (see Appendix B).   
 Hierarchical linear regressions were conducted to further examine the moderating 
effect of gender on the relationship between the stress variables and CRP, controlling for 
adiposity.  Tables 14 through 17 summarize the four analyses (gender and education, 
gender and income, gender and depression diagnosis, and gender and depression 
symptoms).  All analyses indicate significant main effects for gender, with females 
having higher logCRP values than males.  In addition, there was a significant main effect 
for income (t(1) = -3.37, p < 0.01) in the hypothesized directions.   There was also a 
significant interaction between gender and income (t(1) = 2.42, p < 0.05).  The addition 
of this interaction resulted in a small, yet statistically significant, increase in variance 
accounted for (∆R2 = 0.001; t(3380) = 6.087, p < 0.05).    
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Table 14 
Summary of Hierarchical Regression Analysis for Gender and Education Predicting 
LogCRP      
Variable B SE B     β    ∆R2 F(11,3611) p 
Step 2    0.037*** 96.31 <0.001 
     Gender 0.448 0.034 
 
0.215***    
     Education -0.027 0.020 -0.022    
Step 3        0.000 41.73 <0.001 
     Gender 0.351 0.086 
 
0.169***    
     Education -0.092 0.057 -0.075    
     Education x Gender 0.044 0.036  0.074    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, body mass index, and waist circumference) variables presented are those that are 
relevant to the hypotheses.  R2 = 0.190 for Step 1, F(9,3613) = 93.94, p < .0001; R2 = .227 for Step 2;        
R2 = .227 for Step 3.  ***p < .001. 
 
 
Table 15 
 
Summary of Hierarchical Regression Analysis for Gender and Income Predicting 
LogCRP           
Variable B SE B     β    ∆R2 F(11,3368) p 
Step 2    0.038*** 88.51 <0.001 
     Gender 0.429 0.036   0.206***    
     Income -0.018 0.006 - 0.053***    
Step 3        0.002* 81.74 <0.001 
     Gender 0.252 0.081   0.121**    
     Income -0.057 0.017 - 0.164***    
     Gender x Income 0.026 0.011   0.141*    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, body mass index, and waist circumference) variables presented are those that are 
relevant to the hypotheses.  R2 = 0.186 for Step 1, F(9,3370) = 85.56, p < .0001; R2 = .224 for Step 2;        
R2 = .226 for Step 3.  *p < .05, **p < .01, ***p < .001. 
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Table 16 
 
Summary of Hierarchical Regression Analysis for Gender and Depression Diagnosis 
Predicting LogCRP         
Variable B SE B     β    ∆R2 F(11,567) p 
Step 2    0.069*** 21.01 <0.001 
     Gender 0.647 0.089 0.273***    
     Depression Diagnosis 0.193 0.172 0.040    
Step 3        0.001 19.35 <0.001 
     Gender 0.670 0.092 0.282***    
     Depression Diagnosis 0.757 0.568 0.158   
 
     Gender x Depression Diagnosis -0.360 0.345 -0.125   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, body mass index, and waist circumference) variables presented are those that are 
relevant to the hypotheses.  R2 = 0.221, F(9, 569) = 17.93, p < .001 for Step 1; R2 = 0.290 for Step 2; R2 = 
0.291 for Step 3.  ***p < .001. 
 
 
 
Table 17 
 
Summary of Hierarchical Regression Analysis for Gender and Depression Symptoms 
Predicting LogCRP       
Variable B SE B     β    ∆R2 F(11,567) p 
Step 2    0.068*** 20.97 <0.001 
     Gender 0.645 0.089 0.272***    
     Depression Symptoms 0.019 0.020 0.035    
Step 3        0.002 19.33 <0.001 
     Gender 0.678 0.094 0.286***    
     Depression Symptoms 0.090 0.067 0.163   
 
     Gender x Depression Symptoms -0.045 0.040 -0.135   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, body mass index, and waist circumference) variables presented are those that are 
relevant to the hypotheses.  R2 = 0.221, F(9, 569) = 17.93, p < .001 for Step 1; R2 = 0.289 for Step 2; R2 = 
0.291 for Step 3.  ***p < .001. 
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Regression lines were plotted to gain a better understanding of the nature of the 
interaction between gender and income (see Figure 4).  The slope of the regression line 
for females did not significantly differ from zero (B = -0.006; t(3367) = -0.722, p > 0.05), 
suggesting no effect of income on logCRP for this group.  Conversely, males demonstrate 
the expected positive relationship between income and logCRP (B = -0.031, t(3367) = -
4.067, p < 0.01).   
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Figure 4.  Gender moderates the relationship between income and concentration of 
logCRP.  Values for Income represent the income brackets described in the methods 
section: 1 = $0 to $4, 999; 2 = $5,000 to $9,999; 3 = $10,000 to $14,999; 4 = $15,000 to 
$19,999; 5 = $20,000 to $24,999; 6 = $25,000 to $34,999; 7 = $35,000 to $44,999; 8 = 
$45,000 to $54,999; 9 = $55,000 to $64,999; 10 = $65,000 to $74,999; 11 = $75, 000 and 
over.   
*slope is significantly different than zero. 
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Gender as a Moderator of the Relationship between Adiposity and CRP 
 Hierarchical linear regressions were conducted to determine whether gender 
moderates the relationship between adiposity and CRP, controlling for stress variables 
(i.e., education, income, depression diagnosis, and depression symptoms).  Analyses in 
both the SES and depression samples indicate significant main effects for gender and 
BMI in step 2.  However, the interaction term is not significant when entered into the 
model in step 3 (see Appendix C, Tables C1 and C2).  The analyses that examine the 
interaction between gender and WC also show significant main effects of gender and WC 
in step 2.  In addition, the results indicate a significant, but small, interaction between 
gender and WC (t(1) = 1.98, p < 0.05) in the depression sample and an effect that 
approached significance (t(1) = 1.91, p = 0.056) in the SES sample. However, the 
addition of the gender by WC interaction does not significantly increase the R2 in any 
model (see Appendix C, Tables C3 and C4).     
The Relationship of BMI versus WC to CRP 
 It has been suggested that BMI and WC may have different effects on health and 
inflammation (Bjorntorp, 1988).  Therefore, the effects of BMI and WC on CRP were 
compared.  In the SES sample, the correlation between WC and logCRP was slightly 
higher than the correlation between BMI and logCRP (see Table 3).  However, in the 
Depression sample  the correlation between BMI and logCRP was slightly higher than 
between WC and logCRP (see Table 9).  In both cases the differences are very small.  To 
further explore this question, regression analyses were conducted.  The analyses 
controlled for all other variables in step one.  In step two BMI or WC was added to the 
model and in step three the other adiposity measure was included (i.e., WC or BMI).  In 
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the SES sample, each measure of adiposity accounted for significantly more variance 
when entered in to the equation.  The addition of WC to a model including BMI resulted 
in ∆R2 = 0.0194 (F(1,3611) = 90.30, p < 0.01).   The addition of BMI to a model 
containing WC resulted in ∆R2 = 0.0012 (F(1,3611) = 5.59, p = 0.018).  In the 
Depression sample the addition of WC resulted in a significantly higher amount of 
variance accounted for (∆R2 = 0.017; F(1,527) = 13.01, p < 0.01) but the addition of BMI 
did not (∆R2 = 0.003; F(1,527) = 1.96, p = 0.163). This suggests that WC, a measure of 
central adiposity as opposed to overall adiposity, may have a slightly stronger 
relationship with CRP.    
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 Discussion 
Stress and Inflammation   
 The first goal of the study was to determine the relationship between stress and 
inflammation. Low SES has been identified as a chronic stressor (e.g., Kessler, 1979; 
Turner, Wheaton, & Lloyd, 1995) and has been associated with increased rates of 
morbidity and mortality (Adler et al., 1994).  Two major components of SES, educational 
attainment and income level, were examined as proxies for stress in this study.  Results 
indicated that those with lower SES had higher concentrations of CRP.  These findings 
are consistent with previous studies that found higher levels of CRP in individuals in 
lower social classes compared to their more affluent counterparts (e.g., McDade et al., 
2006; Owen et al., 2003; Panagiotakos et al., 2004).   
 Stress has also been conceptualized as a psychological reaction to a stressor 
(Mason, 1975).  Further, depressive symptoms and major depressive disorder have been 
associated with the occurrence of stressors (Holahan et al., 1999; Kendler et al., 1998; 
Kendler et al., 1999).  Thus, these constructs were employed to gain a better 
understanding of the inflammatory responses to such psychological responses.  These 
analyses did not suggest a relationship between depression and CRP; this is contrary to 
previous research that has identified relationships between these variables (e.g., Danner et 
al., 2004; Miller et al., 2002, Owen & Steptoe, 2003; Suarez, et al., 2003). 
There are multiple explanations for the difference in findings between previous 
studies and the current one.  For example, in a sample of well-functioning elderly 
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individuals (70 – 79 years of age, M = 73.6 years, SD = 2.8), Penninx et al. (2003) found 
a significant difference in CRP, IL-6, and TNF-α between those who scored above the 
clinical cut-off (i.e., 16) on the Center for Epidemiological Studies Depression (CES-D) 
scale and those with scores below the cut-off.  Similarly, Vetta et al. (2001) found 
differences in a number of biological markers, including TNF-α and CRP concentrations, 
in depressed compared to control participants in a sample of individuals ranging in age 
from 65 to 94 years (M = 80.1, SD = 12.4).  Conversely, the depression sample in the 
current study consisted of those 20 to 39 years of age, with a mean age of 28.97 years 
(SD = 5.74).  Age is positively associated with inflammation (Suarez, 2004), therefore the 
disparity in ages between the samples may account for the difference in findings.  These 
data, along with the findings of the present study, suggest that the relationship between 
CRP and depression may only be present in the elderly.   
The lack of a relationship between the measures of depression and CRP may also 
be due to the measure of depression that was employed in this study.  The CIDI asked 
participants about their depressive episodes over the previous year.  The data did not 
indicate how recently the depressive episode occurred, therefore it is possible that 
participants were recalling depressive episodes that they experienced months before and 
had since recovered. Danner et al. (2003) reported that participants who experienced a 
depressive episode more than six months before measurement of CRP exhibited levels 
that are similar to those who have never had a depressive episode.  Thus, it is possible 
that the participants in this study had previously experienced a depressive episode 
accompanied by increased levels of CRP, which returned to normal following recovery 
from the episode. 
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Although this study did not find a relationship between CRP and depression, one 
cannot rule out the possibility that inflammation is related to depression.  The 
inflammatory response is very complex and involves many cytokines, proteins, and 
catecholamines.  Therefore, the lack of a relationship between depression and CRP in this 
sample may not be generalizable to the entire inflammatory process.  That is, 
inflammation may still be increased in those with depression, through mechanisms other 
than CRP.  In fact, other studies that have examined multiple biomarkers have failed to 
find a relationship between depression and CRP, though they have found relationships 
with other inflammatory markers (Joyce et al., 1992; Tuglu et al., 2003).    
Adiposity and Inflammation   
A second goal of this study was to explore the relationship between adiposity and 
inflammation.  Previous studies have suggested that adipose tissue is involved in 
secretion of inflammatory markers such as IL-6, TNF-α, and CRP (Calabro et al., 2005; 
Lemieux et al., 2001; Mohamed-Ali et al., 1997; Mohamed-Ali et al., 1998; Owen & 
Steptoe, 2003; Visser et al., 1999; Yudkin et al., 1999).   Therefore it was expected that 
those with more adipose tissue would have higher levels of such inflammatory markers.  
Indeed, across all analyses there were significant associations between measures of 
adiposity (both BMI and WC) and CRP concentration, which is consistent with the 
findings of other researchers (e.g., Owen & Steptoe, 2003; Kern et al., 1995; Lemieux et 
al., 2001; McDade et al., 2006; Mohamed-Ali et al., 1997; Visser et al., 1999; Yudkin et 
al., 1999). 
 Further, it has been suggested that central adiposity is a better predictor of 
obesity-related diseases than overall adiposity (Bjorntorp, 1988).    Likewise, some 
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researchers have found that WC is better at predicting CRP than BMI and total body fat 
percentage (McDade et al., 2006).   However, others have found a relationship between 
CRP and BMI, but not waist-to-hip ratio, particularly in samples of depressed participants 
(Miller et al., 2002).  While the data from the current study suggest that WC may be a 
slightly better predictor of CRP, the differences were very small.  Thus, they did not 
provide convincing evidence that WC is more influential than BMI.  Both measures were 
related to inflammation and appear to be useful predictors of the inflammatory response.   
Interactions between the Stress and Adiposity Variables 
 The third goal of this study was to investigate the proposed model, which 
integrates the effects of stress and the effects of obesity on the inflammatory system.  
Given that adipose tissue secretes pro-inflammatory cytokines and CRP and that stress is 
related to increases in inflammation, it was hypothesized that adiposity would moderate 
the effect of stress on inflammation.   The proposed model suggested that individuals 
with more adiposity would be more affected by stress, demonstrating greater changes in 
levels of CRP under stress than those with less adiposity.   
Analysis of the data revealed interactions between the SES variables and 
adiposity but no interactions between the depression variables and adiposity.  
Interestingly, the nature of the interactions differed from the expected pattern (see 
Figures 1 – 3).  The plots of the regression lines indicated that adiposity was positively 
related to higher CRP.  However, while CRP was not related to income or education 
levels among those with higher levels of adiposity, individuals with lower levels of 
adiposity demonstrated the expected relationship.  That is, they had lower levels of 
inflammation than those with more adiposity and their level of CRP was positively 
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related to the amount of stress they were experiencing, as measured by two indices of 
SES, income and education. 
 These findings may suggest that under less stress (i.e., higher SES), inflammation 
in those with more adiposity remains at levels that are similar to those observed in high 
stress situations.  This is consistent with research that shows that having too much 
adiposity is detrimental to health.  That is, even in non-stressful situations, those with 
high levels of adiposity exhibit levels of inflammation that are similar to those seen in 
people living in stressful conditions.  This explanation lends credence to theories that 
suggest that physiological factors may be more important than psychosocial factors in 
determining health.  Accordingly, if a person has an abundance of adipose tissue, stress 
may not dramatically impact the level of inflammation.  In terms of the proposed model it 
may suggest that adipose tissue is constantly secreting inflammatory markers to the point 
where a ceiling is reached, preventing stress from further influencing the levels of these 
markers. This interpretation highlights the importance of successful weight management 
before stress management can be productive at reducing inflammation because a high 
level of adiposity may overshadow any effect of stress management on inflammation.  
However, having low levels of adiposity is not enough to ensure healthy levels of CRP. 
Those with less adiposity are affected by chronic stress, making stress management more 
important once weight is at healthy levels.   
 An alternative explanation emphasizes the psychological factors that are 
associated with obesity.  Some have suggested that the state of being obese is itself a 
stressor.    In a national sample of adults, Carr and Friedman (2005) found that compared 
to participants who were in the normal weight range, very obese subjects (BMI ≥ 35) 
56 
reported less self-acceptance, more discrimination, and poorer overall health.  The obese 
and very obese participants were 40 to 50% more likely to report experiences of major 
discrimination than normal weight participants. It is possible that the stress of being 
obese may be more detrimental than the stress of living at low SES.  It may be that the 
level of inflammation is higher across all obese participants regardless of their SES 
because they are all faced with equal stressors that because of their weight.  The stress of 
living at low SES may not add a significant amount of stress on top of being obese.  This 
interpretation also suggests the utility of weight management as a way to manage stress, 
improve psychological well-being and lower levels of inflammation.   
 Unfortunately the validity of this explanation is not clear.  In this sample there 
were no significant correlations between the measures of adiposity and depression 
diagnosis and there was only a small correlation between depression symptoms and BMI.  
Thus, those with more adiposity did not appear to be more depressed.  Further, there were 
no correlations between the SES variables and the adiposity variables.  The lack of 
relationships between the adiposity and stress variables suggests that those with more 
adiposity may not be experiencing more stress.  Future research would benefit from 
measuring and controlling for these types of stress and stigmatization to determine the 
pure effect of SES.   
Gender 
 A secondary goal of this study was to examine the relationship of gender to 
inflammation.  The only previous study that examined the interaction between obesity 
and depression on inflammation studied only men (Ladwig et al., 2003).  Therefore, it 
was not clear that the results could be generalized to women.  In addition, other studies 
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have suggested that depression is related to increased levels of CRP in men but not 
women (Danner et al., 2003; Ford & Erlinger, 2004; Liukkonen et al., 2006).   However, 
others have not found gender differences in the effect of SES on CRP (Owen et al., 
2003).    
Given the conflicting data regarding the effects of gender and stress on CRP, 
analyses were conducted to determine the role of gender in these data.  All analyses that 
included gender demonstrate a main effect of gender, indicating that females have higher 
levels of CRP than males, which is consistent with previous research (McDade, 2006).  
There were no significant gender x stress x adiposity interactions, suggesting that the 
relationships between stress and adiposity do not differ across genders.   
However, there was a small but significant two-way interaction between gender 
and income, indicating that the relationship between income and CRP is negative for 
males, but not females.  This is contrary to the findings of Owen et al. (2003) but 
consistent with previously reported data on the effect of depression on CRP 
concentrations (Danner et al., 2003; Ford & Erlinger, 2004; Liukkonen et al., 2006).  
Interestingly, the interactions between depression variables and gender were not 
significant.  This analysis suggests that CRP levels in males and females may be 
differentially affected by stress, underscoring the need to examine inflammatory 
responses in males and females separately rather than simply controlling for gender.  It 
also suggests that care should be taken when generalizing results, as the relationships 
seen in males may not be present in females.   
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 Strengths of the Study  
 This study had several important strengths.  The size of the sample indicates a 
high degree of external validity.  The analyses were conducted using a large, nationally-
representative sample, making the results generalizable to the population of the United 
States.  The analyses that are discussed are those that did not utilize the sampling 
weights.  However, the results were similar when the sample weights were used, 
demonstrating the generalizability of the data even without the use of the weights.  The 
size of the sample also allows for adequate representation of minorities and individuals at 
all levels of SES.    
 Another strength of this study is that it included measures of two types of stress: 
SES (including education and income) and depression (including symptoms and 
diagnosis).  The ability to look at multiple stressors and psychological factors allowed for 
more specific knowledge of how stress affects CRP levels and interacts with adiposity.  
In addition, the variables were treated as continuous.  Researchers often split SES 
variables into high and low groups, losing important information about the gradation of 
the effect.  By using continuous variables in the current analysis, it was possible to 
determine the effects of stress and adiposity on CRP at all values of the variables.   
 These analyses also statistically controlled for factors that are known to be 
associated with CRP, SES, and adiposity.  By controlling for race, smoking, age, gender 
and use of medications, the effects of stress and adiposity on CRP independent of these 
confounds could be identified.  In addition, those who had levels of CRP that are 
indicative of active infections were eliminated from the analyses.  This ensured that the 
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effects that were seen in these data are common in normal conditions and are not 
accounted for by another infection or acute inflammatory reaction.   
Limitations of the Study 
 Unfortunately, there were also a number of limitations to this study.  Due to the 
correlational nature of this study, one cannot rule out the presence of an unknown third 
variable influencing the stress or adiposity variables and CRP.  These variables, and CRP 
in particular, are known to be affected by many factors.  While this study statistically 
controlled for the effects of race, age, gender (where appropriate), use of blood pressure 
and cholesterol medication, and smoking there are other factors that may have influenced 
the relationship between CRP, adiposity and stress.  For example, other researchers have 
controlled for alcohol intake, history of coronary heart disease, cancer, psychological 
illnesses, endocrinological illnesses, use of other anti-inflammatory drugs, and season 
(e.g., Owen et al., 2003).  While, the elimination of individuals with high concentrations 
of CRP (>1 mg/dL) should have reduced the effects that other illnesses had on the data, 
we did not have access to information on these factors, so their influence could not be 
directly controlled.   
 The nature of the study also introduced some limitations to the analyses.  This 
study was conducted on data obtained from a national epidemiological study.  The 
primary goal of the larger study was to gain a better understanding of Americans’ health 
and nutritional status and there were no direct measures of stress available in the dataset.  
Therefore, two proxies for stress were used (SES and depression).  It is possible that a 
direct measure of stress would have provided different information than those measures 
that were available.  Regardless, this study provided valuable insight into the effects of 
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SES and depression on CRP levels.  Both of these factors have been associated with 
increased risk for cardiovascular disease (eg., Adler & Snibbe, 2003; Frasure-Smith & 
Lespérance, 2005).  Given the relationship between CRP and cardiovascular disease (e.g., 
Albert, Ma, Rifai, Stampfer, & Ridker, 2002; Danesh et al., 1998; Mendall et al., 2000; 
Ridker et al., 2000), it is important to understand how SES and depression affect CRP.   
Similarly, only one measure of inflammation was available in the dataset.  CRP is 
only one of a number of elements involved in the inflammatory process.  It is possible 
that a more comprehensive examination of multiple inflammatory markers would have 
provided more information about the effect of adiposity and stress on inflammation.  
Also, some researchers have found relationships between stress and other markers of 
inflammation, such as haptogloblin, α-l-antichymotrypsin, IL-6 and TNF-α, but not with 
CRP (e.g., Grossi et al., 2003; Joyce et al., 1992; Sutherland et al., 2003; Tuglu et al., 
2003).  However, CRP is believed to be one of the best markers of risk for cardiovascular 
disease (Albert et al., 2002; Cushman, Stampfer, Tracy, & Hennekens, 1997; Danesh, 
Collins, Appleby, & Peto, 1998; Pearson et al., 2003; Ridker et al., 2000), therefore, it is 
important that we understand the influences on this inflammatory marker in particular.   
Another constraint on the current analysis was that the raw SES data was not 
made available to the public.  Only information regarding general level of education was 
provided, i.e. if the individual had less than a high school education, a high school 
education, or more than a high school education.  In addition, the income data was also 
only available in income brackets.  Use of categories may have masked the effects of SES 
on CRP.  If this data could have been analyzed in its more detailed form (i.e., exact 
income or number of years of education), it may have provided better information about 
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the relationships between education, income and CRP.  However, these multiple 
categories provide a more continuous variable than analyses in which the SES data was 
divided into only high and low groups.  Therefore, though not ideal, this type of data was 
useful in illustrating the gradation of CRP concentrations across levels of SES.   
The depression analyses also suffered due to the design of the study.  Some 
studies that have found CRP and depression relationships have sampled equal groups of 
depressed and non-depressed, whereas the current study was population-based.  While 
this increased external validity, it also decreased the proportion of depressed participants.  
Only 6.62% (n = 39) of the sample met the criteria for major depression.  In addition, 
only 12.56% (n = 74) of the participants reported one or more symptoms of depression.  
If a sample of depressed participants were specifically selected for this study a more 
normal distribution of symptom frequency may have been obtained, which may have 
affected the results.  
The scope of the CIDI may have also affected the data.  The questionnaire asked 
about symptoms of depression over the previous year.  The participants’ responses may 
have been subject to retrospective memory bias which may have affected their ability to 
accurately recall the events of a major depressive episode that occurred months ago.  As 
previously discussed, only a subsample of participants ages 20 to 39 years were asked to 
complete the CIDI.  This reduced sample of relatively young participants may have had a 
substantial impact on the findings.  There was also no way to know if the participants 
were currently taking antidepressant medications.  Lanquillon et al.’s (2000) study 
suggested that these medications impact levels of CRP.  It is possible that those who had 
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experienced depressive symptoms had been taking medication that affected the 
relationship between the symptoms and the CRP level. 
The correlational and cross-sectional nature of the analyses does not allow for 
conclusions regarding causality.  One cannot be sure if low SES causes changes in CRP 
or if high CRP levels affect SES.  There are multiple hypotheses regarding the direction 
of the relationship between SES and health.  There is a possibility that an increase in 
inflammation could inhibit an individual’s ability to achieve higher education or income.  
However, the consensus in the literature seems to be that low SES leads to poorer health 
(Adler et al., 1994).   
The directionality of the relationship between depression and inflammation has 
raised even more questions and hypotheses.  It is possible that the presence of depression 
symptoms results in an increase in inflammation.  Indeed, researchers have demonstrated 
that alleviating depression lowers levels of inflammatory markers (Lanquillon et al., 
2000; Tuglu et al., 2003).  However, others have found that increased inflammation can 
lead to depressed mood.  Wright, Strike, Brydon and Steptoe (2005) injected participants 
with a low dose of S. typhi capsular polysaccharide vaccine or saline solution in the 
morning.  The vaccination contained a level of antigen that was sufficient to cause an 
inflammatory response (increase in IL-6) but not cause physical symptoms in the 
participants.  They found that the participants who had been injected with the antigen 
reported a more negative mood throughout the day, compared to those who received 
saline.  There was also a correlation between the amount of increase of IL-6 and the 
change in mood, with those who had more IL-6 production showing an increase in 
measures of negative mood.  It is likely that the relationship between depression and 
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inflammation is even more complex.  Miller and Blackwell (2006) present a model in 
which chronic stressors elicit an increase in inflammation.  In response to the increased 
inflammation, people may develop depressive symptoms and cardiovascular disease.  The 
depressive symptoms and cardiovascular disease then participate in perpetuating the 
heightened inflammation, creating a positive feedback loop (Miller & Blackwell, 2006).  
These contradictory studies and models that suggest bidirectional effects make it difficult 
to interpret the results of this study.  There is obviously a need for more experimental and 
longitudinal studies to tease apart the cause and effect or bidirectional relationships 
between stress, adiposity, and CRP.   
There were also some statistical limitations to the analyses.  While a large sample 
increases reliability and external validity, one must keep in mind that it also has its 
drawbacks.   The large sample size may have overpowered the analyses such that even 
small effects could be statistically significant. In addition, multiple statistical tests were 
conducted, which may have inflated the alpha, resulting in an increase in type 1 errors.   
Another statistical difficulty was the non-normality of the depression data.  The data was 
skewed due to the fact that many participants reported no symptoms of depression.  
Transformations of the data were unsuccessful at normalizing, causing the researcher to 
conduct the analyses on non-normal data.  This may have reduced the confidence that one 
has in the results and conclusions. 
Conclusions 
The purpose of this study was to integrate two lines of research.  There is 
substantial evidence suggesting that psychological stress is related to inflammation (e.g. 
Hapuarachchi et al., 2003; Melamed et al., 2004; Owen et al., 2003) and that adiposity is 
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also related to inflammation (e.g. Lemieux et al., 2001; Visser et al., 1999; Yudkin et al., 
1999).  The proposed model led to the hypothesis that stress would cause adipose tissue 
to secrete more cytokines and APPs than it would under normal circumstances.  
Therefore, the relationship between stress and inflammation was expected to be 
moderated by adiposity.  Indeed, adiposity did moderate the relationship between stress 
and inflammation; however, not in the hypothesized direction.  The obese participants in 
this sample exhibited higher levels of inflammation than the normal weight participants, 
regardless of income and education.  In contrast, among normal weight individuals, 
income and education were related to CRP levels.  While the relationship between SES 
and CRP is different for obese and normal weight individuals, the reason for these 
differences is still unclear.   
 Epidemiological data suggest that obesity is reaching epidemic proportions in the 
United States in both children and adults (Hedley et al., 2004; Wyatt, Winters & Dubbert, 
2006).  Further, high levels of adiposity have been linked to a number of chronic diseases 
(e.g., Burton et al., 1985; Hartz, Rupley, & Rimm, 1984; Ohlson et al., 1985).  In 
addition, stress (specifically SES and depression) is known to be a risk factor for 
cardiovascular disease.  It has been suggested that inflammation may be one pathway 
through which adiposity and stress lead to these health complications.  This study 
demonstrates the relationship between these variables and especially highlights the 
dramatic impact of adiposity on inflammation.  While lowering stress may be beneficial 
at reducing CRP in individuals at healthy weights, it does not appear to be enough in 
those with high levels of adiposity.  This is probably due to both the biological and 
psychological factors that are associated with obesity.  Adipose cells release 
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inflammatory materials.  Therefore, those with larger or a greater number of adipose cells 
may be releasing more of these dangerous substances.   Further, obesity is associated with 
psychological distress such as low self-acceptance and experiences of discrimination 
(Carr & Friedman, 2005).  These psychological factors possibly increase inflammatory 
markers on top of any other stress with which these people are faced.  This highlights the 
importance of successful weight management to improve both physiological and 
psychological health.   
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Table A1 
Summary of Hierarchical Regression Analysis for Education and BMI Predicting 
LogCRP: Weighted Data 
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.156*** 123.33 <0.001 
     Education - 0.015 0.027    
     BMI   0.076*** 0.003    
Step 3       0.000 168.40 <0.001 
     Education - 0.157 0.102    
     BMI   0.064*** 0.010    
     Education x BMI   0.005 0.003    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI 
= body mass index (kg/m2).   R2 = 0.067, F (8,15) = 48.58, p < 0.001 for Step 1; R2 = 0.223 for Step 2; R2 = 
0.223 for Step 3.   ***p < .001 
 
Table A2 
Summary of Hierarchical Regression Analysis for Education and WC Predicting 
LogCRP: Weighted Data     
Variable B SE B    ∆R2 F(10, 15) p 
Step 2   0.164*** 125.65 <0.001 
     Education - 0.014 0.027    
     WC   0.032*** 0.001    
Step 3       0.000 147.22 <0.001 
     Education - 0.138 0.168    
     WC   0.029*** 0.005    
     Education x WC   0.001 0.002    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  WC 
= waist circumference (cm). R2 = 0.067, F (8, 15) = 48.58, p < 0.001 for Step 1; R2 = 0.232 for Step 2;  R2 = 
0.232 for Step 3.  *p < .05, ***p < .001 
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Table A3 
Summary of Hierarchical Regression Analysis for Income and BMI Predicting LogCRP: 
Weighted Data        
Variable      B SE B ∆R2 F(10, 15) p 
Step 2   0.159*** 230.58 <0.001 
     Income - 0.023*** 0.006    
     BMI   0.077*** 0.003    
Step 3       0.002* 285.22 <0.001 
     Income - 0.106** 0.030    
     BMI   0.055*** 0.009    
     Income x BMI   0.003** 0.001    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI 
= body mass index (kg/m2).  R2 = 0.067, F(8, 15) = 48.58, p < 0.001 for Step 1; R2 = .226for Step 2; R2 = 
.228 for Step 3.  **p < .01, ***p < .001 
 
Table A4 
Summary of Hierarchical Regression Analysis for Income and WC Predicting LogCRP: 
Weighted Data 
Variable    B SE B    ∆R2 F(10, 15) p 
Step 2   0.167*** 132.26 <0.001 
     Income - 0.021** 0.006    
     WC   0.032*** 0.001    
Step 3       0.001   144.39 <0.001 
     Income - 0.078 0.049    
     WC   0.028*** 0.004    
     Income x WC   0.001 0.000    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  WC 
= waist circumference (cm). R2 = 0.067, F (8, 15) = 48.58, p < 0.001 for Step 1; R2 = 0.234 for Step 2; R2 = 
0.235 for Step 3.  **p < .01, ***p < .001 
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Table A5 
Summary of Hierarchical Regression Analysis for Depression Diagnosis and BMI 
Predicting LogCRP: Weighted Data          
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.181*** 498.77 <0.001 
     Depression Diagnosis  0.090 0.156    
     BMI 0.085*** 0.006    
Step 3       0.000   666.85 <0.001 
     Depression Diagnosis  0.472 0.529    
     BMI  0.087*** 0.006    
     Depression Diagnosis x BMI -0.014 0.014    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  
BMI= body mass index (kg/m2).  R2 = 0.077, F (8, 15) = 83.84, p < 0.001 for Step 1; R2 = 0.258 for Step 2; 
R 2= 0.2581 for Step 3.  ***p < .001 
 
 
Table A6 
 
Summary of Hierarchical Regression Analysis for Depression Diagnosis and WC 
Predicting LogCRP: Weighted Data           
Variable    B SE B ∆R2 F(10, 15) p 
Step 2   0.167*** 214.67 <0.001 
     Depression Diagnosis 0.093 0.189    
     WC 0.032 0.003    
Step 3       0.000  311.30 <0.001 
     Depression Diagnosis  0.564 0.596    
     WC  0.033*** 0.003    
     Depression Diagnosis x WC 0.005 0.005    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  
WC=Waist Circumference (cm).  R2 = 0.077, F (8, 15) = 83.84, p < 0.001 for Step 1; R2 = 0.244 for Step 2; 
R 2= 0.244 for  Step 3.  ***p < .001 
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Table A7 
Summary of Hierarchical Regression Analysis for Depression Symptoms and BMI 
Predicting LogCRP: Weighted Data                                                                                                                                  
Variable     B SE B ∆R2 F(10, 15) p 
Step 2   0.180*** 834.67 <0.001 
     Depression Symptoms   0.007 0.011    
     BMI 
  
0.085*** 0.005    
Step 3       0.000 1017.33 <0.001 
     Depression Symptoms  -0.002 0.081    
     BMI 
  
0.084*** 0.007   
 
     Depression Symptoms x BMI   0.000 0.002    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.   
BMI = body mass index (kg/m2).  R2 = 0.077, F (8, 15) = 83.84, p < 0.001 for Step 1; R2 = 0.257 for Step 2;   
R 2= 0.257 for Step 3. ***p < .001 
 
 
Table A8 
 
Summary of Hierarchical Regression Analysis for Depression Symptoms and WC 
Predicting LogCRP: Weighted Data 
Variable     B SE B   ∆R2 F(10, 15) p 
Step 2   0.161*** 272.21 <0.001 
     Depression Symptoms  0.007 0.013    
     WC  0.033*** 0.003    
Step 3       0.000 356.19 <0.001 
     Depression Symptoms -0.001 0.107    
     WC  0.032*** 0.003    
     Depression Symptoms x WC  0.000 0.001    
Note. All steps contain the covariates (gender, age, ethnicity, use of blood pressure medication, use of 
cholesterol medication and smoking) variables presented are those that are relevant to the hypotheses.  WC 
= Waist Circumference (cm).   R2 = 0.077, F(8,15) = 83.84, p < .0001 for Step 1; R2 = .238 for Step 2;      
R2 = .238 for Step 3.  ***p < .001.
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Table A9 
 
Summary of Hierarchical Regression Analysis for Education, BMI, and Gender 
Predicting LogCRP: Weighted Data 
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.167*** 123.33 <0.001 
     Education  -0.015 0.027    
     BMI  0.076*** 0.003    
     Gender  0.276*** 0.037    
Step 3       0.001 195.75 <0.001 
     Education  -0.245 0.126    
     BMI   0.057** 0.015    
     Gender - 0.014 0.239    
     Education x BMI   0.005 0.003    
     Education x Gender   0.064 0.049    
     BMI x Gender   0.005 0.007    
Step 4   0.000 204.13 <0.001 
     Education -0.546 0.502    
     BMI  0.032 0.042    
     Gender -0.467 0.771    
     Education x BMI  0.016 0.016    
     Education x Gender  0.255 0.307    
     BMI x Gender  0.021 0.025    
     Education x BMI x Gender -0.007 0.010    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI= body 
mass index (kg/m2).  R2 = 0.056, F (7, 15) = 46.44, p < 0.001 for Step 1; R2 = 0.223 for Step 2; R 2= 
0.224for Step 3; R 2= 0.224 for Step 4.  **p < .01, ***p < .001. 
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Table A10 
 
Summary of Hierarchical Regression Analysis for Education, WC, and Gender 
Predicting LogCRP: Weighted Data     
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.176*** 125.65 <0.001 
     Education -0.014 0.027    
     WC  0.032*** 0.001    
     Gender  0.476*** 0.042    
Step 3       0.002** 186.40 <0.001 
     Education -0.311 0.206    
     WC  0.019* 0.007    
     Gender  0.002 0.002    
     Education x WC -0.016 0.015    
     Education x Gender  0.096 0.051    
     WC x Gender  0.006* 0.003    
Step 4   0.000 181.71 <0.001 
     Education -0.228 0.726    
     WC  0.021 0.017    
     Gender -0.207 1.152    
     Education x WC  0.001 0.007    
     Education x Gender  0.040 0.471    
     WC x Gender  0.005 0.011    
     Education x WC x Gender  0.001 0.005    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC = waist 
circumference (cm).  R2 = 0.056, F (7, 15) = 46.44, p < 0.001 for Step 1; R2 = 0.232 for Step 2; R 2= 0.234 
for Step 3; R 2= 0.234 for Step 4.  ***p < .001, **p < .01, *p < .05 
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Table A11 
 
Summary of Hierarchical Regression Analysis for Income, BMI, and Gender Predicting 
LogCRP: Weighted Data        
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.170*** 230.58 <0.001 
     Income -0.023*** 0.006    
     BMI  0.077*** 0.003    
     Gender 0.251*** 0.035    
Step 3       0.004** 293.17 <0.001 
     Income -0.140** 0.036    
     BMI  0.043** 0.012    
     Gender -0.096 0.227    
     Income x BMI  0.003** 0.001    
     Income x Gender  0.021 0.012    
     BMI x Gender  0.007 0.006    
Step 4   0.000 921.96 <0.001 
     Income -0.133 0.111    
     BMI  0.045 0.027    
     Gender -0.064 0.480    
     Income x BMI  0.002 0.004    
     Income x Gender  0.016 0.065    
     BMI x Gender  0.006 0.015    
     Income x BMI x Gender  0.0001 0.002    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI= body 
mass index (kg/m2).  R2 = 0.056, F (7, 15) = 46.44, p < 0.001 for Step 1; R2 = 0.226 for Step 2; R 2= 0.230 
for Step 3; R 2= 0.230 for Step 4.  **p < .01, ***p < .001. 
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Table A12 
 
Summary of Hierarchical Regression Analysis for Income, WC, and Gender Predicting 
LogCRP: Weighted Data 
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.178*** 132.26 <0.001 
     Income  -0.021** 0.006    
     WC  0.032*** 0.001    
     Gender  0.454*** 0.041    
Step 3       0.005** 233.75 <0.001 
     Income   -0.157* 0.062    
     WC   0.016* 0.006    
     Gender  -0.440 0.254    
     Income x WC   0.001 0.0005    
     Income x Gender   0.033* 0.012    
     WC x Gender   0.007** 0.002    
Step 4   0.000 276.35 <0.001 
     Income  -0.105 0.128    
     WC  0.020* 0.009    
     Gender -0.189 0.545    
     Income x WC  0.0003 0.001    
     Income x Gender -0.001 0.074    
     WC x Gender  0.004 0.005    
     Income x WC x Gender  0.0003 0.00    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC = Waist 
Circumference (cm).  R2 = 0.056, F(7, 15) = 46.44, p < 0.001 for Step 1; R2 = 0.234 for Step 2; R2= 0.239 
for Step 3; R2= 0.239 for Step 4.  *p < .05, **p < .01, ***p < .001. 
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Table A13 
 
Summary of Hierarchical Regression Analysis for Depression Diagnosis, BMI, and 
Gender Predicting LogCRP: Weighted Data          
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.219*** 498.77 <0.001 
     Depression Diagnosis 0.090 0.156    
     BMI 0.085*** 0.006    
     Gender 0.548*** 0.094    
Step 3       0.002 591.49 <0.001 
     Depression Diagnosis  0.991* 0.461    
     BMI  0.074** 0.020    
     Gender  0.347 0.339    
     Depression Diagnosis x BMI -0.016 0.015    
     Depression Diagnosis x Gender -0.297 0.322    
     BMI x Gender -0.008 0.012    
Step 4   0.000 869.54 <0.001 
     Depression Diagnosis  0.623 2.024    
     BMI  0.073** 0.022    
     Gender  0.329 0.376    
     Depression Diagnosis x BMI -0.002 0.070    
     Depression Diagnosis x Gender -0.094 1.153    
     BMI x Gender  0.009 0.014    
     Depression Diagnosis x BMI x Gender -0.008 0.037    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI= body 
mass index (kg/m2).  R2 = 0.039, F (7, 15) = 105.87, p < 0.001 for Step 1; R2 = 0.258 for Step 2; R 2= 0.260 
for Step 3; R 2= 0.260 for Step 4.  ***p < .001, **p < .01, *p < .05 
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Table A14 
 
Summary of Hierarchical Regression Analysis for Depression Diagnosis, WC, and 
Gender Predicting LogCRP: Weighted Data       
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.205*** 214.67 <0.001 
     Depression Diagnosis 0.093 0.189    
     WC 0.032 0.003    
     Gender 0.685*** 0.095    
Step 3       0.004 604.34 <0.001 
     Depression Diagnosis  1.377* 0.588    
     WC  0.021 0.010    
     Gender -0.078 0.629    
     Depression Diagnosis x WC -0.009* 0.004    
     Depression Diagnosis x Gender -0.286 0.317    
     WC x Gender  0.009 0.007    
Step 4   0.000 419.16 <0.001 
     Depression Diagnosis  2.538 2.704    
     WC  0.022 0.011    
     Gender -0.029 0.664    
     Depression Diagnosis x WC -0.021 0.028    
     Depression Diagnosis x Gender -0.945 1.514    
     WC x Gender  0.008 0.007    
     Depression Diagnosis x WC x 
Gender  0.007 0.016   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC=Waist 
Circumference (cm).  R2 = 0.039, F (7, 15) = 105.87, p < 0.001 for Step 1; R2 = 0.244 for Step 2; R 2= 0.248 
for Step 3, R 2= 0.248 for Step 4.  *p < .05, ***p < .001 
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Table A15 
 
Summary of Hierarchical Regression Analysis for Depression Symptoms, BMI, and 
Gender Predicting LogCRP: Weighted Data           
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.218*** 834.67 <0.001 
     Depression Symptoms 0.007 0.011    
     BMI 0.085*** 0.005    
     Gender 0.549*** 0.094    
Step 3       0.001 1680.61 <0.001 
     Depression Symptoms  0.042 0.083    
     BMI  0.076** 0.020   
 
     Gender  0.417 0.324   
 
     Depression Symptoms x BMI  0.0002 0.003   
 
     Depression Symptoms x Gender -0.027 0.043   
 
     BMI x Gender  0.006 0.012   
 
Step 4   0.001 1681.86 <0.001 
     Depression Symptoms  0.192 0.266   
 
     BMI  0.080** 0.023   
 
     Gender  0.488 0.385   
 
     Depression Symptoms x BMI -0.005 0.009   
 
     Depression Symptoms x Gender -0.111 0.154   
 
     BMI x Gender  0.003 0.014   
 
     Depression Symptoms x BMI x Gender  0.003 0.005   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.   BMI = body 
mass index (kg/m2).  R2 = 0.039, F (7, 15) = 105.87, p < 0.001 for Step 1; R2 = 0.257 for Step 2;    
R 2= 0.258 for Step 3; R 2= 0.259 for Step 4. **p < .01, ***p < .001 
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Table A16 
 
Summary of Hierarchical Regression Analysis for Depression Symptoms, WC, and 
Gender Predicting LogCRP: Weighted Data 
Variable     B SE B    ∆R2 F(10, 15) p 
Step 2   0.199*** 272.21 <0.001 
     Depression Symptoms 0.007 0.013    
     WC 0.033*** 0.003    
     Gender 0.673*** 0.098    
Step 3       0.008 133.82 <0.001 
     Depression Symptoms  0.020 0.080    
     WC  0.022* 0.010    
     Gender  0.014 0.609    
     Depression Symptoms x WC  0.00003 0.001    
     Depression Symptoms x Gender -0.011 0.040    
     WC x Gender  0.007 0.007    
Step 4   0.001 375.69 <0.001 
     Depression Symptoms  0.444 0.350    
     WC  0.025* 0.012    
     Gender  0.238 0.698    
     Depression Symptoms x WC -0.004 0.004    
     Depression Symptoms x Gender -0.266 0.193    
     WC x Gender  0.005 0.008    
     Depression Symptoms x WC x Gender  0.003 0.002    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC = Waist 
Circumference (cm).  R2 = 0.039, F (7, 15) = 105.87, p < 0.001 for Step 1; R2 = .238 for Step 2; R2 = .246 
for Step 3; R2 = .247 for Step 4.  *p < .05, ***p < .001. 
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Table A17 
 
Summary of Hierarchical Regression Analysis for Gender and Education Predicting 
LogCRP: Weighted Data      
Variable     B SE B   ∆R2 F(11,15) p 
Step 2   0.026*** 122.18 <0.001 
     Gender 
                     
0.398*** 0.049    
     Education -0.015 0.028    
Step 3       0.001 132.23 <0.001 
     Gender 0.217 0.120    
     Education -0.128 0.089    
     Education x Gender 0.076 0.051    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, body mass index, and waist circumference) variables presented are those that are 
relevant to the hypotheses.  R2 = 0.211, F(9,15) = 134.60, p < .001 for Step 1; R2 = .237 for Step 2;  
R2 = .238 for Step 3.  ***p < .001. 
 
 
 
Table A18 
Summary of Hierarchical Regression Analysis for Gender and Income Predicting 
LogCRP: Weighted Data         
Variable B SE B   ∆R2 F(11,15) p 
Step 2   0.028*** 157.15 <0.001 
     Gender  0.377*** 0.051    
     Income -0.022** 0.006    
Step 3       0.002* 155.17 <0.001 
     Gender  0.186 0.096    
     Income -0.060** 0.019    
     Gender x Income  0.025* 0.011    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, body mass index, and waist circumference) variables presented are those that are 
relevant to the hypotheses.  R2 = 0.211, F(9,15) = 134.60, p < .0001 for Step 1; R2 = .239 for Step 2; R2 = 
.241 for Step 3.  *p < .05, **p < .01, ***p < .001. 
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Table A19 
Summary of Hierarchical Regression Analysis for Gender and Depression Diagnosis 
Predicting LogCRP: Weighted Data         
Variable      B SE B ∆R2 F(11,15) p 
Step 2   0.055*** 836.16 <0.001 
     Gender 
 
0.592*** 0.088    
     Depression Diagnosis  0.089 0.166    
Step 3       0.001 910.08 <0.001 
     Gender 
 
0.614*** 0.087    
     Depression Diagnosis  0.550 0.518    
     Gender x Depression Diagnosis -0.294 0.348    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, body mass index, and waist circumference) variables presented are those that are 
relevant to the hypotheses.  R2 = 0.203 F(9, 15) = 219.63, p < .001 for Step 1; R2 = 0.258 for Step 2; R2 = 
0.259 for Step 3.  ***p < .001. 
  
 
 
Table A20 
Summary of Hierarchical Regression Analysis for Gender and Depression Symptoms 
Predicting LogCRP: Weighted Data       
Variable B SE B ∆R2 F(11,15) p 
Step 2   0.055*** 1265.33 <0.001 
     Gender  0.593*** 0.089    
     Depression Symptoms  0.007 0.012    
Step 3       0.000 1062.00 <0.001 
     Gender  0.611*** 0.090    
     Depression Symptoms  0.040 0.058    
     Gender x Depression Symptoms -0.021 0.042    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, body mass index, and waist circumference) variables presented are those that are 
relevant to the hypotheses.  R2 = 0.203 F(9, 15) = 219.63, p < .001 for Step 1; R2 = 0.258 for Step 2; R2 = 
0.258 for Step 3.  ***p < .001. 
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Table A21 
Summary of Hierarchical Regression Analysis for Gender and BMI Predicting LogCRP 
(The SES Sample): Weighted Data 
Variable     B SE B ∆R2 F(11,15) p 
Step 2   0.164*** 207.45 <0.001 
     Gender 0.251*** 0.035    
     BMI 0.077*** 0.003    
Step 3       0.000 217.57 <0.001 
     Gender 0.098 0.183    
     BMI 0.068*** 0.010    
     Gender x BMI 0.005 0.006    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, education, and income) variables presented are those that are relevant to the 
hypotheses.  These analyses utilized the sampling weights.  BMI = body mass index.   R2 = 0.063, F(9, 15) 
= 33.41, p < .0001 for Step 1; R2 = 0.227 for Step 2; R2 = 0.227 for Step 3.  ***p < .001 
 
 
 
Table A22 
Summary of Hierarchical Regression Analysis for Gender and BMI Predicting LogCRP    
(The Depression Sample): Weighted Data           
Variable    B SE B ∆R2 F(11,583) p 
Step 2   0.215*** 811.48 <0.001 
     Gender 0.548*** 0.094    
     BMI 0.085*** 0.006    
Step 3       0.000 719.22 <0.001 
     Gender 0.401 0.312    
     BMI 0.076** 0.021    
     Gender x BMI 0.005 0.013    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, depression diagnosis, and depression symptoms) variables presented are those that 
are relevant to the hypotheses.  These analyses utilized sampling weights.  BMI = body mass index.  
R2 = 0.043, F(9, 15) = 94.82, p < .001 for Step 1; R2 = 0.258 for Step 2; R2 = 0.258 for Step 3.  
**p< .01, ***p< .001. 
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Table A23 
Summary of Hierarchical Regression Analysis for Gender and WC Predicting LogCRP 
(the SES sample): Weighted Data   
Variable      B SE B ∆R2 F(11,15) p 
Step 2   0.172*** 119.08 <0.001 
     Gender  0.453*** 0.041    
     WC  0.032*** 0.001    
Step 3       0.001** 190.49 <0.001 
     Gender -0.139 0.224    
     WC  0.023*** 0.004    
     Gender x WC  0.006* 0.002    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, education, and income) variables presented are those that are relevant to the 
hypotheses.  These analyses utilized sampling weights.  WC = waist circumference (cm).  R2 = 0.063,  
F(9, 15) = 33.41, p < .001 for Step 1; R2 = .235 for Step 2; R2 = 0.236 for Step 3. **p < .01, ***p < .001. 
 
 
Table A24 
 
Summary of Hierarchical Regression Analysis for Gender and WC Predicting LogCRP 
(the Depression Sample): Weighted Data               
Variable     B SE B ∆R2 F(11,15) p 
Step 2   0.201*** 554.23 <0.001 
     Gender 0.685*** 0.095    
     WC 0.032*** 0.003    
Step 3       0.002 1600.32 <0.001 
     Gender 0.015 0.022    
     WC 0.022 0.010    
     Gender x WC 0.007 0.007    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, depression diagnosis, and depression symptoms) variables presented are those that 
are relevant to the hypotheses.  These analyses utilized sampling weights.  WC = waist circumference (cm). 
R2 = 0.043, F(9, 15) = 94.82, p < .001 for Step 1; R2 = 0.244 for Step 2; R2 = 0.246 for Step 3. ***p< .001. 
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Table B1 
Summary of Hierarchical Regression Analysis for Education, BMI, and Gender 
Predicting LogCRP: Unweighted Data 
Variable     B SE B     β ∆R2 F(10, 3681) p 
Step 2    0.159*** 93.50 <0.001 
     Education  -0.028 0.020 -0.023    
     BMI  0.069 0.003 
 
0.381***    
     Gender  0.304 0.031 
 
0.146***    
Step 3        0.001 72.40 <0.001 
     Education  -0.266 0.104 -0.217*    
     BMI   0.055 0.011 
 
0.303***   
 
     Gender   0.256 0.180  0.123    
     Education x BMI   0.007 0.003  0.176*    
     Education x Gender   0.031 0.037  0.051    
     BMI x Gender -0.001 0.006 -0.009    
Step 4    0.000 67.46 <0.001 
     Education -0.750 0.304 -0.611*    
     BMI  0.017 0.025  0.095    
     Gender  -0.422 0.438 -0.203    
     Education x BMI -0.024 0.011  0.621*    
     Education x Gender  0.339 0.185  0.564    
     BMI x Gender  0.024 0.015  0.386    
     Education x BMI x Gender -0.011 0.007 -0.550    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI= body 
mass index (kg/m2).  R2 = 0.044, F (7, 3684) = 24.33, p < 0.001 for Step 1; R2 = 0.203 for Step 2; R 2= 
0.204 for Step 3; R 2= 0.204 for Step 4.  *p < .05, **p < .01, ***p < .001. 
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Table B2 
 
Summary of Hierarchical Regression Analysis for Education, WC, and Gender 
Predicting LogCRP: Unweighted Data     
Variable     B SE B    β    ∆R2 F(10, 3621) p 
Step 2    0.181*** 105.36 <0.001 
     Education -0.025 0.020 -0.020    
     WC  0.031 0.001  0.426***    
     Gender  0.482 0.032  0.231***    
Step 3        0.003** 82.01 <0.001 
     Education  -0.417 0.145 -0.339**    
     WC   0.019 0.004  0.257***   
 
     Gender -0.0002 0.234 -0.0001   
 
     Education x WC  0.003 0.001  0.261*   
 
     Education x Gender  0.062 0.037  0.103   
 
     WC x Gender  0.004 0.002  0.174   
 
Step 4    0.000 76.15 <0.001 
     Education -0.587 0.405 -0.477   
 
     WC  0.015 0.010  0.205   
 
     Gender -0.252 0.607 -0.121   
 
     Education x WC  0.005 0.004  0.406   
 
     Education x Gender  0.175 0.254  0.291   
 
     WC x Gender  0.006 0.006  0.297   
 
     Education x WC x Gender -0.001 0.003 -0.184   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC = waist 
circumference (cm).  R2 = 0.044, F (7, 3684) = 24.33, p < 0.001 for Step 1; R2 = 0.225 for Step 2; R 2= 
0.228 for Step 3; R 2= 0.228 for Step 4.  ***p < .001, **p < .01, *p < .05 
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Table B3 
 
Summary of Hierarchical Regression Analysis for Income, BMI, and Gender Predicting 
LogCRP: Unweighted Data        
Variable     B SE B β    ∆R2 F(10,3434) p 
Step 2    0.157*** 86.53 <0.001 
     Income -0.021 0.006 -0.060***    
     BMI 0.069 0.003 0.377***    
     Gender 0.280 0.032 0.135***    
Step 3        0.004** 67.84 <0.001 
     Income -0.134 0.031 -0.384***    
     BMI  0.046 0.012 0.253***    
     Gender  0.072 0.179  0.035    
     Income x BMI  0.003 0.001  0.256**    
     Income x Gender  0.021 0.011 0.253*    
     BMI x Gender  0.003 0.006 0.117    
Step 4    0.000 62.98 <0.001 
     Income -0.155 0.092 -0.446    
     BMI  0.041 0.024  0.225    
     Gender -0.017 0.399 -0.008    
     Income x BMI  0.004 0.003  0.325    
     Income x Gender  0.035 0.055  0.190    
     BMI x Gender  0.006 0.014  0.093    
     Income x BMI x Gender 0.0004 0.002 -0.077    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI= body 
mass index (kg/m2).  R2 = 0.044, F (7, 3684) = 24.33, p < 0.001 for Step 1; R2 = 0.201 for Step 2; R 2= 
0.205 for Step 3; R 2= 0.205 for Step 4.  ***p < .001, **p < .01, *p < .05 
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Table B4 
 
Summary of Hierarchical Regression Analysis for Income, WC, and Gender Predicting 
LogCRP: Unweighted Data 
Variable     B SE B     β    ∆R2 F(10, 3378) p 
Step 2    0.179*** 96.96 <0.001 
     Income  -0.018 0.006 -0.050**    
     WC  0.031 0.001  0.421***    
     Gender  0.459 0.033  0.221***    
Step 3        0.004** 76.09 <0.001 
     Income  -0.151 0.043 -0.433***    
     WC  0.017 0.004  0.238***   
 
     Gender -0.233 0.240 -0.112   
 
     Income x WC  0.001 0.0004 0.263*   
 
     Income x Gender  0.032 0.011 0.173**   
 
     WC x Gender  0.005 0.002 0.239*   
 
Step 4    0.000 70.64 <0.001 
     Income  -0.159 0.121 -0.456   
 
     WC  0.017 0.009  0.231   
 
     Gender -0.268 0.553 -0.129   
 
     Income x WC  0.001 0.001  0.287   
 
     Income x Gender  0.037 0.074  0.200   
 
     WC x Gender  0.005 0.006  0.256   
 
     Income x WC x Gender -0.0001 0.001 -0.027   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC=Waist 
Circumference (cm).  R2 = 0.044, F (7, 3684) = 24.33, p < 0.001 for Step 1; R2 = 0.223 for Step 2; R 2= 
0.227 for Step 3; R 2= 0.227 for Step 4.  ***p < .001, **p < .01, *p < .05 
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Table B5 
 
Summary of Hierarchical Regression Analysis for Depression Diagnosis, BMI, and 
Gender Predicting LogCRP: Unweighted Data          
Variable     B SE B       β    ∆R2 F(10, 572) p 
Step 2    0.239*** 21.79 <0.001 
     Depression Diagnosis 0.175 0.171   0.037    
     BMI 0.087 0.007 
  
0.444***    
     Gender 0.569 0.087 
  
0.241***    
Step 3        0.002 16.87 <0.001 
     Depression Diagnosis  1.133 0.821  0.239    
     BMI  0.080 0.023 
 
0.407***   
 
     Gender  0.447 0.406  0.189   
 
     Depression Diagnosis x BMI -0.010 0.022 -0.062   
 
     Depression Diagnosis x Gender -0.432 0.345 -0.152   
 
     BMI x Gender -0.006 0.015  0.079   
 
Step 4    0.000 15.65 <0.001 
     Depression Diagnosis  0.297 2.833  0.063   
 
     BMI  0.078 0.024  0.397**   
 
     Gender  0.409 0.424  0.173   
 
     Depression Diagnosis x BMI  0.020 0.100  0.126   
 
     Depression Diagnosis x Gender  0.034 1.551  0.012   
 
     BMI x Gender  0.007 0.015  0.098   
 
     Depression Diagnosis x BMI x Gender -0.017 0.054 -0.178   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  BMI= body 
mass index (kg/m2).  R2 = 0.037, F (7, 575) = 3.17, p < 0.01 for Step 1; R2 = 0.276 for Step 2; R 2= 0.278 for 
Step 3; R 2= 0.278 for Step 4.  ***p < .001, **p < .01, *p < .05 
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Table B6 
 
Summary of Hierarchical Regression Analysis for Depression Diagnosis, WC, and 
Gender Predicting LogCRP: Unweighted Data       
Variable     B SE B    β    ∆R2 F(10, 568) p 
Step 2    0.249*** 22.72 <0.001 
     Depression Diagnosis 0.206 0.172  0.043    
     WC 0.036 0.003 
 
0.463***    
     Gender 0.679 0.087 
 
0.287***    
Step 3        0.005 17.81 <0.001 
     Depression Diagnosis  1.551 1.191  0.324    
     WC  0.022 0.009  0.284*   
 
     Gender -0.197 0.537 -0.083   
 
     Depression Diagnosis x WC -0.008 0.010 -0.162   
 
     Depression Diagnosis x Gender -0.371 0.348 -0.129   
 
     WC x Gender  0.010 0.006  0.406   
 
Step 4    0.000 16.51 <0.001 
     Depression Diagnosis  1.113 4.263  0.233   
 
     WC  0.022 0.009  0.281*   
 
     Gender -0.212 0.556 -0.090   
 
     Depression Diagnosis x WC -0.004 0.043 -0.071   
 
     Depression Diagnosis x Gender -0.124 2.339 -0.043   
 
     WC x Gender  0.010 0.006  0.413   
 
     Depression Diagnosis x WC x Gender -0.003 0.024 -0.085   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC=Waist 
Circumference (cm).  R2 = 0.037, F (7, 571) = 3.11, p < 0.01 for Step 1; R2 = 0.286 for Step 2; R 2= 0.291 
for Step 3, R 2= 0.291 for Step 4.  *p < .05, ***p < .001 
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Table B7 
 
Summary of Hierarchical Regression Analysis for Depression Symptoms, BMI, and 
Gender Predicting LogCRP: Unweighted Data           
Variable     B SE B     β    ∆R2 F(10, 572) p 
Step 2    0.239*** 21.79 <0.001 
     Depression Symptoms 0.020 0.020  0.037    
     BMI 0.087 0.007 
 
0.443***    
     Gender 0.568 0.087 
 
0.244***    
Step 3        0.003 16.94 <0.001 
     Depression Symptoms  0.103 0.099  0.189    
     BMI  0.080 0.023 
 
0.407***   
 
     Gender  0.497 0.406  0.210   
 
     Depression Symptoms x BMI  0.001 0.003  0.030   
 
     Depression Symptoms x Gender -0.063 0.040 -0.193   
 
     BMI x Gender  0.005 0.015  0.062   
 
Step 4    0.001 15.74 <0.001 
     Depression Symptoms  0.302 0.346 0.551   
 
     BMI  0.085 0.025 0.434***   
 
     Gender  0.590 0.435 0.249   
 
     Depression Symptoms x BMI -0.007 0.012 -0.358   
 
     Depression Symptoms x Gender -0.175 0.191 -0.534   
 
     BMI x Gender  0.002 0.016 0.015   
 
     Depression Symptoms x BMI x Gender  0.004 0.007 0.373   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.   BMI = body 
mass index (kg/m2).  R2 = 0.037, F (7, 575) = 3.17, p < 0.01 for Step 1; R2 = 0.276 for Step 2;   R 2= 0.279 
for Step 3; R 2= 0.280 for Step 4. ***p < .001 
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Table B8 
 
Summary of Hierarchical Regression Analysis for Depression Symptoms, WC, and 
Gender Predicting LogCRP: Unweighted Data 
Variable      B SE B      β    ∆R2 F(10, 568) p 
Step 2    0.248*** 22.68 <0.001 
     Depression Symptoms  0.021 0.020  0.039    
     WC  0.036 0.003 
 
0.461***    
     Gender  0.677 0.088 
 
0.286***    
Step 3        0.005 17.73 <0.001 
     Depression Symptoms   0.098 0.143  0.178    
     WC   0.022 0.009  0.282*   
 
     Gender  -0.153 0.538 -0.065   
 
     Depression Symptoms x WC  -0.0001 0.001 -0.020   
 
     Depression Symptoms x Gender -0.042 0.041 -0.127   
 
     WC x Gender   0.009 0.006  0.389   
 
Step 4    0.001 16.49 <0.001 
     Depression Symptoms  0.453 0.480 0.817   
 
     WC  0.024 0.009 0.314*   
 
     Gender  -0.003 0.573 -0.001   
 
     Depression Symptoms x WC -0.004 0.005 -0.662   
 
     Depression Symptoms x Gender -0.248 0.270 -0.750   
 
     WC x Gender  0.008 0.006 0.321   
 
     Depression Symptoms x WC x Gender  0.002 0.003 0.624   
 
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication and smoking) variables presented are those that are relevant to the hypotheses.  WC = Waist 
Circumference (cm).   R2 = 0.037, F (7, 571) = 3.11, p < 0.01 for Step 1; R2 = .285 for Step 2; R2 = .290 for 
Step 3; R2 = .291 for Step 4.  *p < .05, ***p < .001. 
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Table C1 
 
Summary of Hierarchical Regression Analysis for Gender and BMI Predicting LogCRP 
(The SES Sample) 
Variable B SE B   β    ∆R2 F(11,3430) p 
Step 2    0.151*** 78.69 <0.001 
     Gender 0.282 0.032 0.136***    
     BMI 0.069 0.003 0.377***    
Step 3        0.000 72.12 <0.001 
     Gender 0.249 0.163 0.120    
     BMI 0.067 0.010 0.366***    
     Gender x BMI 0.001 0.006 0.019    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, education, and income) variables presented are those that are relevant to the 
hypotheses.  These analyses did not utilize the sampling weights.  BMI = body mass index.   R2 = 0.051, 
F(9, 3432) = 20.48,  
p < .0001 for Step 1; R2 = 0.202 for Step 2; R2 = 0.202 for Step 3.  ***p < .001 
 
 
Table C2 
 
Summary of Hierarchical Regression Analysis for Gender and BMI Predicting LogCRP    
(The Depression Sample)           
Variable B SE B   β    ∆R2 F(11,571) p 
Step 2    0.231*** 19.79 <0.001 
     Gender 0.568 0.087 0.240***    
     BMI 0.087 0.007 0.443***    
Step 3        0.000 18.12 <0.001 
     Gender 0.479 0.398 0.203    
     BMI 0.082 0.023 0.418***    
     Gender x BMI 0.003 0.014 0.045    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, depression diagnosis, and depression symptoms) variables presented are those that 
are relevant to the hypotheses.  These analyses did not utilize sampling weights.  BMI = body mass index. 
R2 = 0.045, F(9, 573) = 3.01, p< 0.01 for Step 1; R2 = 0.276 for Step 2; R2 = 0.276 for Step 3. 
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Table C3 
 
Summary of Hierarchical Regression Analysis for Gender and WC Predicting LogCRP 
(the SES sample)   
Variable B SE B   β    ∆R2 F(11,3374) p 
Step 2    0.174*** 87.97 <0.001 
     Gender 0.461 0.033 0.222***    
     WC 0.030 0.001 0.420***    
Step 3        0.001 81.01 <0.001 
     Gender 0.037 0.224 0.018    
     WC 0.024 0.004 0.330***    
     Gender x WC 0.004 0.002 0.209    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, education, and income) variables presented are those that are relevant to the 
hypotheses.  These analyses did not utilize sampling weights.  WC = waist circumference (cm).  R2 = 0.049, 
F(9, 3376) = 19.50, p < .001 for Step 1; R2 = .223 for Step 2; R2 = 0.224 for Step 3. ***p < .001. 
 
 
Table C4 
 
Summary of Hierarchical Regression Analysis for Gender and WC Predicting LogCRP 
(the Depression Sample)               
Variable B SE B   β    ∆R2 F(11,567) p 
Step 2    0.242*** 20.63 <0.001 
     Gender 0.677 0.086 0.286***    
     WC 0.036 0.003 0.462***    
Step 3        0.003 19.16 <0.001 
     Gender -0.134 0.531 -0.057    
     WC 0.023 0.009 0.293*    
     Gender x WC 0.009 0.006 0.366    
Note. All steps contain the covariates (age, ethnicity, use of blood pressure medication, use of cholesterol 
medication, smoking, depression diagnosis, and depression symptoms) variables presented are those that 
are relevant to the hypotheses.  These analyses did not utilize sampling weights.  WC = waist 
circumference. R2 = 0.044, F(9,569) = 2.90, p< 0.01 for Step 1; R2 = 0.286 for Step 2; R2 = 0.289 for  
Step 3.   
